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Abstract
MOLECULAR MECHANISMS OF INWARD AND OUTWARD
BUDDING FROM MULTIVESICULAR ENDOSOMES
Monica Gireud Goss, M.S.
Advisory Professor: Andrew Bean, Ph.D.

Regulating the residence time of membrane proteins (e.g. transporters, ion
channels, receptors) on the cell surface can modify their response to extracellular
cues and allow for cellular adaptation to environmental conditions. The fate of
membrane proteins that are internalized from the plasma membrane and arrive at
the limiting membrane of the late endosome/multivesicular body (MVB) is dictated by
whether they remain on the limiting membrane, bud into internal MVB vesicles, or
bud outwardly from the membrane. The molecular details underlying the disposition
of membrane proteins that transit this pathway and the mechanisms regulating these
trafficking events are unclear. We established a cell-free system that reconstitutes
budding of membrane protein cargo into internal MVB vesicles and onto vesicles
that bud outwardly from the MVB membrane. Both budding reactions are cytosoldependent and supported by Saccharomyces cerevisiae (yeast) or Drosophila
melanogaster (fly) cytosol, providing a system amenable to genetic manipulation.
We observed that inward and outward budding are mechanistically distinct but may
be linked, such that inhibition of inward budding enhances outward budding.
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Chapter 1. Introduction
1.1 Endocytosis of membrane proteins
Membrane proteins (e.g. receptors, ion channels, and transporters) reside on
the plasma membrane and respond to signals from the extracellular environment
that affect global cellular processes such as growth, proliferation, and differentiation.
The removal of membrane proteins from the cellular surface tunes environmental
signaling by preventing their continued activation by extracellular molecules,
although the termination of their signaling activity may not occur until their lysosomal
degradation (Gruenberg, 2001; Sorkin and von Zastrow, 2009; Sun et al., 2010).
The canonical endocytic pathway for cell surface transmembrane proteins
begins with their internalization into vesicles that bud from the plasma membrane
and fuse with each other or with early endosomes (Fig. 1.1) (Gruenberg, 2001;
Sorkin and von Zastrow, 2009). Early endosomes may mature into late endosomes
and subsequently into multivesicular bodies (MVBs). MVBs are formed when the
endosomal limiting membrane invaginates producing vesicles that separate from the
limiting membrane resulting in an organelle containing internal vesicles (Eden et al.,
2012; Futter et al., 1996; Gruenberg, 2001; Lemmon and Traub, 2000; Sorkin and
von Zastrow, 2009; Sun et al., 2010). The fate of membrane proteins that move
through this pathway depends on whether they enter the internal vesicles or remain
on the limiting MVB membrane (Fig. 1.1) (Eden et al., 2012; Felder et al., 1990;
Futter et al., 1996; Sirisaengtaksin et al., 2014). Membrane proteins that move from
the limiting membrane into internal vesicles of MVBs are degraded upon MVBlysosome fusion or are secreted into the extracellular space as exosomes upon
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MVB-plasma membrane fusion (Corrado et al., 2013; Hurley and Odorizzi, 2012;
Kowal et al., 2014). Membrane proteins that are not sorted into internal MVB
vesicles can remain on the limiting membrane and become incorporated into the
lysosomal membrane upon MVB-lysosome fusion (Fig. 1.1) (Eden et al., 2012;
Futter et al., 1996; Katzmann et al., 2002; Piper and Luzio, 2001; Raymond et al.,
1992a) or may bud from the limiting endosomal membrane for recycling to various
cellular compartments (e.g. the plasma membrane, Golgi apparatus, endoplasmic
reticulum) (Felder et al., 1990; Gruenberg, 2001; Sun et al., 2010). Coordination of
membrane protein degradation and recycling regulates cell surface protein
composition and signaling (Grant and Donaldson, 2009).

1.2. Epidermal Growth Factor Receptor Trafficking
The Epidermal Growth Factor Receptor (EGFR), is a type I transmembrane
protein that is a prototypical cell-surface signaling receptor (Cohen, 1962; Goh and
Sorkin, 2013; Tomas et al., 2014). The EGFR contains an extracellular ligandbinding domain, a single membrane-spanning domain, and a cytoplasmic tyrosine
kinase-containing domain (Olayioye et al., 2000; Riese and Stern, 1998). Binding of
EGFR to its ligand promotes its dimerization and auto-phosphorylation of the
tyrosine residues on the cytoplasmic tail (Chung et al., 2010). The autophosphorylation activates the downstream signal transduction pathways (Olayioye et
al., 2000; Riese and Stern, 1998). EGFR activation results in its internalization via
clathrin-mediated endocytosis and subsequent movement through the endocytic
pathway resulting in lysosomal degradation.

An alternative pathway for EGFR
2

following internalization allows escape from lysosomal trafficking and recycling back
to the plasma membrane for further signaling.
Alterations in membrane protein trafficking can alter cellular responses to
ligand activation. For example, a truncated EGFR mutant, EGFRvIII, is expressed in
50% of glioblastoma tumors (Frederick et al., 2000; Furnari et al., 2007; Gan et al.,
2009; Heimberger et al., 2005; Sugawa et al., 1990). EGFRvIII lacks the receptor
ectodomain, and is internalized independent of ligand binding and moves through
the endocytic pathway (Grandal et al., 2007). It follows the same itinerary as wildtype EGFR, but constitutively recycles to the plasma membrane (Grandal et al.,
2007). The enhanced recycling of EGFRvIII results in increased surface expression,
and uncontrolled cell proliferation and signaling, behaviors that may underlie
glioblastoma pathogenesis (Grandal et al., 2007). The mechanisms regulating the
intracellular trafficking of EGFRvIII are unclear.

3

Figure 1.1: The Endocytic Pathway. Internalized membrane proteins are initially
transported to early endosomes.

From the early or sorting endosomes, protein

cargo can be recycled and/or transported to multi-vesicular bodies (MVBs). At the
MVB, a membrane protein may bud outwardly for recycling to other cellular
compartments (e.g. plasma membrane), or inwardly forming the internal vesicles of
the MVB whose contents will be degraded upon MVB-lysosome fusion, or secreted
into the extracellular space (exosomes) upon MVB-plasma membrane fusion.
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1.3. Mechanisms of Membrane Budding Events.
Vesicle-mediated trafficking is a process in which cargo and membrane are
transported in membrane-bounded compartments and requires the generation of
membrane transport vesicles that bud from a donor compartment and fuse with an
acceptor

membrane.

Ultimately,

vesicle

budding

allows

for

the

selective

incorporation of cargo proteins into newly synthesized vesicles (Bonifacino and
Glick, 2004). Understanding the requirements for proteins that regulate membrane
budding events have largely been advanced using reconstitution experiments
(Bremser et al., 1999; Matsuoka et al., 1998; Wollert and Hurley, 2010). Vesicle
budding can occur with or without the aid of coat proteins, however little is known
about non-coated vesicle transport. Three classical coat complexes have been
identified that are composed of cytosolic proteins that associate with budding
membranes. Clathrin is a coat that binds indirectly to the donor membrane through
adapter proteins that bind directly to cargo (Farsad and De Camilli, 2003; Honing et
al., 2005), whereas some other coats bind directly to donor membranes to facilitate
cargo clustering and membrane deformation (Bonifacino and Glick, 2004; Harter et
al., 1996; Hurley et al., 2010). I will briefly summarize the current view of coatedvesicle membrane trafficking mechanisms.
1.3.1. Cargo selection and membrane deformation
Cargo selection and membrane deformation must act in concert if the budded
vesicles are carrying cargo. Thus, the mechanism of membrane budding requires,
recognition and clustering of selected cargo for incorporation into regions of the
membrane that will vesiculate (Bonifacino and Glick, 2004). The best understood
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mechanism of cargo selection and membrane deformation occurs in clathrincontaining vesicle (CCV) budding where the adaptor protein-2 complex (AP-2),
directly binds to activated receptors and the plasma membrane phospholipid,
phosphatidylinositol-4,5-bi-sphosphate (PtdIns(4,5)P2) (Honing et al., 2005). After
binding of AP-2, the bin-amphiphysin-rvs (BAR) domain superfamily scaffolding
proteins, amphiphysin, endophilin, and epsin, are recruited (Blood and Voth, 2006;
Castillo et al., 2002; Farsad and De Camilli, 2003; Hurley et al., 2010; Takei et al.,
1999). BAR-domain containing proteins possess intrinsic curvature sensing and
producing properties (Cui et al., 2013; Madsen et al., 2010). Membrane budding is
an energetically unfavorable event (Farsad and De Camilli, 2003; Hurley et al.,
2010) and thus the BAR domain family proteins are required for membrane bending,
curvature, and scission (Farsad and De Camilli, 2003). The BAR domain proteins
bind to PtdIns(4,5)P2 (Lemmon, 2008) and initiate convex curvature and bending of
the membrane to provide a platform for recruitment of the clathrin coat.
1.3.2. Coat Proteins.
Clathrin is a soluble protein that does not bind cargo or membranes and is not
sufficient to generate membrane curvature and bending (Dell'Angelica, 2001;
Nossal, 2001). Therefore, after binding of adaptor proteins that can simultaneously
bind membrane and cargo, clathrin is recruited to the membrane. Polymerizing
clathrin forms a lattice around the forming pits and stabilizes the membrane
curvature that ultimately regulates vesicle size (60-100nm) (McMahon and Boucrot,
2011). Regulatory proteins can alter the polymerization rate of clathrin to keep up
with cellular demand. In contrast to clathrin, that is necessary but not sufficient for
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budding, COP coats directly bind to membranes and, along with associated
GTPases, are both necessary and sufficient to mediate vesicle budding (see section
1.3.4 for a detailed description) (Bethune et al., 2006). Upon coat protein binding,
the vesicles are ready for detachment from donor membranes.
1.3.3. Vesicle Scission.
The final step of vesicle budding requires vesicle fission, the detachment of
vesicles from donor membranes. In CCV, the vesicle fission step is mediated by the
large GTPase dynamin (Sweitzer and Hinshaw, 1998; Yoshida et al., 2004). As the
CCV vesicle invaginates, amphiphysin recruits dynamin, (Yoshida et al., 2004).
Dynamin assembles around the neck of the budding vesicle and GTP hydrolysis
induces a conformational change in dynamin that results in membrane fission and
vesicle release (Ferguson and De Camilli, 2012; Sweitzer and Hinshaw, 1998).
Following vesicle release, an ATPase, heat shock cognate 70 (Hsc70), and its
cofactor, auxilin, remove the clathrin coat before the vesicle is able to fuse with an
acceptor membrane (Eisenberg and Greene, 2007). Transport vesicle fusion with
acceptor membranes is regulated by the Soluble NSF Attachment Protein Receptor
(SNARE) proteins, as vesicle-SNARES on transport vesicles bind to target-SNAREs
on target organelles (Sollner et al., 1993). In CCV, the SNARE proteins together with
the small GTPase Rab5 are required for membrane fusion (Bucci et al., 1992;
Gorvel et al., 1991).

7

1.3.4. Distinct coats mediate different trafficking steps.
Clathrin coated-vesicles (CCV) are involved in budding transport vesicles
from the plasma membrane (Kirchhausen, 2000). The Coatomer (Coat protein
complex I (COPI)) complex plays a role in budding retrogradly-directed transport
vesicles from the Golgi to the Endoplasmic Reticulum (ER), while the COPII complex
is involved in the budding of anterogradly-directed transport vesicles from the Golgi
that are involved in retrograde trafficking to the ER (Kirchhausen, 2000). Thus, in
contrast to the clathrin-mediated process described above, retrograde transport in
the secretory pathway requires the Coatomer (COPI).

The Coatomer complex

consists of 7 subunits (α, β, β’, γ, δ, ε, and ζ-COP) and additional cofactors. COPmediated trafficking differs from the clathrin-dependent process described above
(Bonifacino and Lippincott-Schwartz, 2003).

Initially, the small GTPase ADP-

ribosylation factor (ARF) is recruited to the membrane. Activated ARF provides the
link between cargo binding and coat protein recruitment. ARF recruits the intact
coatomer complex from the cytosol and the GTPase activating protein, ARFGAP1.
The Coatomer complex is preassembled in the cytoplasm into a heptameric complex
consisting of two layers. One layer forms the base of the coat (similar to AP-2 in
CCV) and further binds to membrane through γ-COP (Harter et al., 1996). The
second layer is a cage-like trimeric subcomplex (Yu et al. 2012) that is responsible
for determining vesicle size and initiates polymerization of the coat, leading to
deformation of the membrane. Deactivation of ARF by ARFGAP1 along with
regulatory proteins that enhance ARFGAP1 function are required for vesicle fission
(Goldberg; Hsu and Yang, 2009; Lanoix et al., 2001; Yang et al., 2005). Following
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vesicle fission, ARF deactivation destabilizes the coatomer and leads to vesicle
uncoating before vesicles are competent to fuse with the ER (Spang, 2013).

1.4. The ESCRT Machinery regulates inward budding at MVBs.
The molecular mechanisms underlying membrane protein trafficking have
been illuminated with the help of genetic and cell-free model systems. Studies using
the yeast, Saccharomyces cerevisiae, enabled isolation of proteins required for
inward budding of membrane proteins into the vacuole, the yeast degradative
organelle (Babst et al., 2011; Babst et al., 2002b; Bilodeau et al., 2003; Bowers et
al., 2004; Hurley and Emr, 2006; Katzmann et al., 2001; Piper and Luzio, 2001;
Raymond et al., 1992b; Schmidt and Teis, 2012; Teis et al., 2010). A study by
Rothman et al, (Rothman et al., 1989), revealed the identification of at least 40
genes, the Vacuolar protein sorting (Vps) genes, that when mutated were defective
for the sorting of proteins to the vacuole (Rothman et al., 1989). However it was not
until 1992, when Raymond et al identified a subset of the Vps proteins, known as the
class E Vps proteins, that when mutated accumulated a large, prevacuolar
endosomal compartment and were defective in the formation of MVB internal
vesicles (Raymond et al., 1992a). Characterization of the Class E Vps genes
resulted in identification of the Endosomal Sorting Complexes Required for
Transport (ESCRTs) (Babst et al., 2011; Babst et al., 2002a; Babst et al., 2002b;
Bilodeau et al., 2003; Bowers et al., 2004; Hurley and Emr, 2006; Katzmann et al.,
2001; Katzmann et al., 2003; Kostelansky et al., 2006; Lemmon and Traub, 2000;
Malerod et al.; Piper et al., 1995; Piper and Luzio, 2001; Teis et al., 2010). The
ESCRTs are four cytosolic protein complexes that are recruited to endosomal
9

membranes and enable the sorting of membrane proteins into internal vesicles
(Futter et al.; Hurley and Emr; Katzmann et al., 2001; Lemmon and Traub; Raiborg
and Stenmark, 2009; Wegner et al., 2010). However, we lack a complete
biochemical and molecular understanding of mechanisms that underlie regulation of
ESCRT function, membrane protein movement, and vesicle formation/budding from
the limiting MVB membrane.
The sorting of membrane proteins into the internal vesicles of the MVB
requires their ubiquitination to enable engagement with the sorting machinery
(Bache et al., 2003; Katzmann et al., 2001; Saksena et al., 2007; Sirisaengtaksin et
al., 2014). A protein lacking ubiquitin remains on the limiting membrane and may
remain on the limiting membrane for incorporation into the lysosomal membrane
upon MVB-lysosome fusion or be recycled to the plasma membrane. Membrane
protein cargo that has been ubiquitinated can be recognized by the ESCRT proteins
and sorted into internal vesicles that will be degraded upon MVB-lysosome fusion
(Fig. 1.2a). ESCRT complex formation occurs sequentially such that Vps27 is the
first ESCRT component recruited to endosomal membranes through its second
coiled-coil domain (Raiborg et al., 2001) and its membrane-lipid targeting domain,
FYVE (Fab1, YGL023, Vps27, EEA1) (Gaullier et al., 1998; Gillooly et al., 2000;
Raiborg et al, 2001; Urbe et al, 2000) which binds to the membrane phospholipid,
phosphatidylinositol 3-phosphate (PI3P) (Gaullier et al., 1998; Gillooly et al., 2000;
Raiborg et al, 2001; Urbe et al, 2000; Williams and Urbe, 2007; Katzmann et al,
2001). After recruitment to endosomal membranes, Vps27 binds to cargo via its
ubiquitin-interacting motif (UIM) (Bilodeau et al., 2002; Shih et al., 2002). Vps27 acts
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as a scaffold to recruit Hse1 to form the initial ESCRT complex (ESCRT-0) and in
turn, sequester cargo into clusters. After formation of ESCRT-0, Vps27 binds to
Vps23, a component of ESCRT-I that also binds ubiquitinated cargo (Babst et al.,
2002a; Bache et al., 2003; Hurley and Emr, 2006; Katzmann et al., 2001; Katzmann
et al., 2003). Vps23 recruits the remaining ESCRT-I components (Vps28, Vps37,
and Mvb12a) from the cytoplasm to the endosome. ESCRT-I initiates ESCRT-II
formation (Vps36, Snf8, Vps25) (Babst et al., 2002a; Schmidt and Teis). The
function of the ESCRT-II complex is not well defined but it is believed that ESCRT-II
initiates oligomerization of small coiled-coiled proteins to form ESCRT-III (Vps20,
Snf7, Vps24, and Did4) (Babst et al., 2002a; Hurley and Emr, 2006; Schmidt and
Teis, 2012). The composition of ESCRT-III is not clearly defined, though it is thought
to be composed of two major complexes, Vps20/Snf7 and Vps24/Did4 that act to
concentrate cargo and initiate MVB vesicle formation (Babst et al., 2002a; Hurley
and Emr, 2006; Hurley and Hanson, 2010). Vps20 couples ESCRT-II to ESCRT-III,
binds to the endosomal membranes and triggers oligomerization of Snf7. The
oligomerization of Snf7 is capped by the Vps24/Did4 complex. The ESCRT-III
machinery may be responsible for the fission of invaginated endosomal membrane
that becomes internal MVB vesicles (Fig. 1.2) (Hurley and Emr, 2006; Schmidt and
Teis, 2012). Finally, the AAA ATPase Vps4, acts to hydrolyze ATP and disassemble
the ESCRT machinery (Babst et al., 1998).
The function of the ESCRT components in MVB biogenesis is highly
conserved across multiple organisms, including yeast, flies, worms, and humans.
The importance of the ESCRT machinery was revealed when mutations in the
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ESCRT components rendered a phenotype characterized by enlarged endosomal
compartments (vacuoles/MVBs) and failed transportation of proteins into the internal
vesicles of the vacuole (Bilodeau et al., 2002; Hurley and Hanson, 2010; Schmidt
and Teis). Deletion of some of the class E Vps genes (Vps27, Vps23, and Vps4)
result in impaired MVB biogenesis. The functions of these genes appear to be highly
conserved in mammalian cells (Gruenberg, 2001; Rieder et al., 1996). The depletion
of the mammalian homologs of Vps27, Hse, and Vps4 (Hepatocyte growth factorregulated tyrosine kinase substrate (Hrs), Signal-transducing adaptor molecule
(Madsen et al.), and Vps4 respectively) significantly decreased the number of MVB
internal vesicles formed (Bilodeau et al., 2002; Katzmann et al., 2001;
Sirisaengtaksin et al., 2014; Sun et al., 2010). Additionally, many ESCRT mutations
(Vps27, Hse, Snf7, Vps23) are embryonically lethal in mice (Kanazawa et al., 2003;
Komada and Soriano, 1999; Lloyd et al., 2002; Raymond et al., 1992a), highlighting
the essential nature of the ESCRT machinery.
Two competing models describe the roles of the ESCRT complexes in cargo
sorting. The conveyor belt model, suggests that cargo molecules are handed off
sequentially from one ESCRT complex to the next in a linear manner and is based
on sequential ESCRT protein interactions (Fig. 1.2a) (Hurley and Emr, 2006). The
concentric ring model suggests that a supercomplex of ESCRT-0, ESCRT-I, and
ESCRT-II complexes simultaneously form, cluster, and bind multiple ubiquitinated
cargoes (Fig. 1.2b) (Nickerson et al., 2007). Evidence exists to support both theories
and both models agree that the ESCRT-0 proteins, Hrs and STAM, bind to
ubiquitinated cargo and initiate ESCRT complex formation (Hurley and Emr, 2006;
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Nickerson et al., 2007). A major point of divergence between the two competing
models is how ESCRT complexes bind to ubiquitinated cargo proteins. In contrast to
the conveyor belt model, the concentric ring model assumes that multiple ESCRT
components bind ubiquitinated cargo simultaneously (Nickerson et al., 2007).
However the assumption that ESCRT complexes simultaneously bind ubiquitinated
cargo has not been tested. If the concentric ring model is correct, disruption of an
ESCRT component, or the ubiquitin binding site in an individual ESCRT component,
should reduce, but not completely inhibit MVB internal vesicle formation (Nickerson
et al., 2007). Another point of divergence between the two models is the reliance on
linear formation of ESCRT complexes. In this regard, there is evidence that ESCRTII is not required for MVB internal vesicle formation, at least under some conditions,
arguing against a strict sequential order of ESCRT complex engagement (Bowers et
al., 2006). However, it is possible that the ESCRTs proteins may have redundant
functions allowing for enough flexibility to overcome disruptions in ESCRT-cargo
engagement (Nickerson et al., 2007). Understanding whether all ESCRT complexes
are generally required for cargo sorting and how the ESCRT complexes assemble
on endosomes would aid in clarifying whether either of these models is correct.
The ESCRT machinery regulates two other key processes: viral budding and
cytokinetic abscission (Fig. 1.3). ESCRT-I (TSG101, Vps28, Vps37, and Mvb12a)
and ESCRT-III (Snf7, Did4, Vps24), along with Vps4 and the ESCRT-associated
protein, Apoptosis-Linked Gene 2-Interacting Protein X (Alix), are required for the
release of enveloped retroviruses, including HIV-1 and Ebola, at the plasma
membrane (Hurley and Hanson, 2010; McDonald and Martin-Serrano, 2009). The
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viral HIV-1 GAG protein can assemble and drive vesicle formation, but not scission
in the absence of the ESCRT machinery (Jouvenet et al., 2009). The ESCRT-I
component, TSG101, and Alix are recruited to the plasma membrane by binding to
the HIV-1 Gag protein L-Domain (Demirov et al., 2002; Garrus et al., 2001; MartinSerrano et al., 2001; VerPlank et al., 2001). The L-domain is a 4 amino acid motif in
the HIV-1 Gag protein, that when mutated results in inhibited release of viral proteins
from the plasma membrane (Gottlinger et al., 1991; Huang et al., 1995). Upon
binding to the Gag protein L-domain, Tsg101 then recruits Vps28, Vps37, and
MVB12a while Alix binds to Snf7 and recruits Did4, Vps24 and lastly Vps4. Binding
of the ESCRT components triggers membrane scission and release of viral proteins
into the extracellular environment (Fisher et al., 2007; Martin-Serrano et al., 2003;
McCullough et al., 2008; Strack et al., 2003; Usami et al., 2007; von Schwedler et
al., 2003; Zhai et al., 2008). In similar fashion, ESCRT-I (TSG101, Vps28, Vps37,
and Mvb12a) and ESCRT-III (Snf7, Did4, Vps24), along with Vps4 and Alix are
required for abscission during cytokinesis, the final step of the cell cycle following
mitosis (Carlton and Martin-Serrano, 2007; McDonald and Martin-Serrano, 2009).
The ESCRT machinery is recruited to the membrane neck/midbody between diving
cells by the binding of Alix and Tsg101 to the midbody component, centrosome
protein 55 kDA (Cep55). Disruption of this interaction results in cytokinesis failure
(Carlton and Martin-Serrano, 2007). Tsg101 recruits the ESCRT-I components
(Vps28, Vps37, and Mvb12a) while Alix binds to the ESCRT-III component, Snf7, for
the recruitment of additional ESCRT-III components (Did4 and Vps24) and Vps4
(Carlton et al., 2008; Carlton and Martin-Serrano, 2007; Morita et al., 2007). The
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recruitment of ESCRT-III to the midbody area results in abscission and release of
the daughter cells (Carlton et al., 2008; Carlton and Martin-Serrano, 2007; Morita et
al., 2007). These data suggest a unique ability for ESCRT-I and ESCRT-III proteins
to drive membrane budding and scission events in the absence of ESCRT-0 and
ESCRT-II.
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Figure 1.2: ESCRT function. a) Conveyor belt model of ESCRT function. According
to this model, ESCRT complexes are recruited sequentially to the endosome and
recognize ubiquitinated transmembrane proteins, passing cargo from one complex
to the next to facilitate sorting to MVB vesicles. b) Concentric circle model of ESCRT
function. ESCRT-0, -I and -II mediate cargo recognition, lipid binding and complex
assembly, resulting in formation of an ESCRT-0/I/II supercomplex on the endosomal
membrane with MVB cargo proteins concentrated beneath. Subunits of ESCRT-III
assemble to form a perimeter and promote dissembly by Vps4. Dissociation of the
ESCRT- 0/I/II core precedes vesicle formation, making sequestered MVB cargoes
available for deubiquitination before vesicle scission. a,b) Adapted from Nickerson,
D.P., M.R. Russell, and G. Odorizzi. 2007. A concentric circle model of
multivesicular body cargo sorting. EMBO Rep. 8:644-650. (Nickerson et al., 2007).
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Figure 1.3. The ESCRT machinery regulates multiple budding events. The
ESCRT machinery regulates the formation of internal vesicles within multivesicular
bodies (MVBs), viral budding and abscission during cytokinesis. Adapted from
McDonald, B., and J. Martin-Serrano. 2009. No strings attached: the ESCRT
machinery in viral budding and cytokinesis. Journal of cell science. 122:2167-2177.
(McDonald and Martin-Serrano, 2009).
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1.5. The Mechanism of Outward Vesicle Budding from Endosomes.
Endosomes are dynamic organelles that deliver material to other cellular
compartments via membrane budding (Grant and Donaldson, 2009; Gruenberg,
2001; Maxfield and McGraw, 2004; Tanowitz and von Zastrow; Thompson et al.,
2007; Weigert et al., 2004). The separation and sorting of cargo proteins on
endosomal membranes allows for the selective incorporation of membrane proteins
into newly formed vesicles (Bonifacino and Glick, 2004). Membrane budding into the
cytosol usually requires coat proteins (Kirchhausen, 2000), however the role of coat
proteins in outward budding from late endosomes is unclear. The cytosolic GTPases
are known to regulate outward vesicle budding from early endosomes and the transGolgi (Stenmark, 2009). A non-hydrolysable analogue of GTP, GTPγS, inhibits
budding of cargo between the golgi cisternae (Melancon et al., 1987), from the ER to
Golgi (Baker et al., 1990; Beckers and Balch, 1989; Ruohola et al., 1988), and from
the trans-Golgi network (Tooze et al., 1990). These results led to the identification of
the Ras related proteins in brain (Rab) and suggested that GTPases are regulators
of membrane budding in the endocytic pathway (Segev et al., 1988; Stenmark,
2009). Subsequently, multiple types of GTPases, both small (Rab family) and large
(dynamin) have been implicated in membrane budding events (Pryer et al., 1992;
Robinson, 1994; Salminen and Novick, 1987; Zerial and Stenmark, 1993).
Rab GTPases are the largest family of small GTPases and were originally
implied to regulate vesicle docking and fusion (Gorvel et al., 1991), uncoating
(Semerdjieva et al., 2008) and organelle identity (Stenmark, 2009; Zerial and
McBride, 2001). Rab GTPases regulate vesicle formation (Plutner et al., 1991; Ren

18

et al., 1998) and transport between organelles (Chavrier et al., 1990). Inactivation of
Rab homologs results in enlargement of the Golgi, but not in accumulation of Golgiderived vesicles (Benli et al., 1996; Jedd et al., 1997). Thus, Rab proteins regulate
many membrane trafficking stages (Pfeffer, 2001). Like most GTPases, Rab proteins
function between two alternate conformational states: the active GTP-bound “on”
state and the inactive GDP-bound “off” state (Bourne et al., 1990). For membrane
trafficking events the GTP-bound Rabs are often membrane associated by virtue of
their ability to bind receptors when GTP-bound (Stenmark, 2009; Pfeffer, 2001).
Active Rab proteins are required for transport vesicle formation however; it is still
unclear how Rab proteins regulate vesicle budding events.
Similar to small GTPAses, the large GTPase, dynamin is known to regulate
membrane budding events. Dynamin was initially implicated in vesicle budding due
to its role in vesicle scission of newly formed vesicles via its GTP hydrolysis
capability, both at the plasma membrane and at the Golgi (Urrutia et al., 1997).
Expression of a dominant negative form of Dynamin (DynaminK44A) impaired
vesicle release from the plasma membrane and from endosomes to the Golgi
(Robinson, 1994). Therefore, understanding the role of GTPases in vesicle budding
events is key to understanding membrane trafficking pathways.
GTPases regulate most of the outward budding pathways from endosomes.
There are three main outward budding routes from early endosomes: a direct “fast”
route, an indirect, “slow” route, and an endosome to Trans Golgi network route (Fig.
1.4) (Grant and Donaldson, 2009; Maxfield and McGraw, 2004; Thompson et al.,
2007; Weigert et al., 2004). The fast route is dependent on the small GTPases Rab4
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and Rab5 and can occur prior to fusion of internalized vesicles with the early
endosomes, or through the perinuclear and tubular vesicles that bud off from early
endosomes to form the endosomal recycling compartment (ERC) (Grant and
Donaldson, 2009; van der Sluijs et al., 1992; Xie et al., 2016). In this regard,
overexpression of a dominant negative Rab4, Rab4S22N, results in vesicle
accumulation in the perinuclear area of early endosomes (McCaffrey et al., 2001).
The slow route requires the small GTPase Rab11, and movement through the ERC
(Grant and Donaldson, 2009). The ERC plays a key role in the recycling of the
Transferrin receptor (TfR) back to the plasma membrane for reuse (Ullrich et al.,
1996). Expression of a dominant negative form of Rab11, Rab11S25N, inhibits the
movement of TfR from early/sorting endosomes to the ERC (Ren et al., 1998).
Lastly, the non-GTPase retromer protein complex regulates trafficking of the
mannose-6-phosphate (M6PR) receptor from endosomes to the trans-Golgi network
(Arighi et al., 2004). Depletion of the retromer components, Vps26 or Vps35,
decreases recycling and enhances degradation of M6PR (Arighi et al., 2004).
Therefore, regulation of outward budding from early endosomes is dependent on
Rab GTPases and retromer components. If a receptor does not bud out through one
of the three routes described above, it will be transported to late endosomes,
although the mechanisms of outward budding from late endosomes is not well
understood.
There are two outward budding routes from the late endosomes (Fig. 1.4).
One trafficking route depends on the small GTPase, Rab9 and the large GTPase,
Dynamin. Rab9 and Dynamin regulate the trafficking of M6PR from endosomes to
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the trans-Golgi network (Lombardi et al., 1993; Nicoziani et al., 2000; Riederer et al.,
1994). Lack of Rab9 impairs transport of M6PR between endosomes and the transGolgi network by inhibiting vesicle budding (Lombardi et al., 1993). Similarly,
dynamin is required for transport of M6PR. Dynamin plays a role in vesicle fission
and thus expression of a dominant negative mutant form of Dynamin,
DynaminK44A, impairs the release of vesicles containing M6PR from endosomes to
the trans-Golgi network (Nicoziani et al., 2000). Lastly, transport vesicles can bud
from MVBs prior to MVB-lysosome fusion and may carry cargo to the plasma
membrane for reuse (Felder et al., 1990). Ultrastructural studies of an EGFR mutant
lacking kinase activity, EGFRK721A, revealed that EGFRK721A is found on the limiting
membranes of MVBs prior to budding outwardly into vesicles destined for the
plasma membrane (Felder et al., 1990). The increased recycling of the EGFRK721A
results in an increase in cell-surface expression (Felder et al., 1990). However, the
molecular mechanisms underlying this outward vesicle budding from the MVB is not
well understood and is the focus of this study.
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Figure 1.4. Membrane Protein Trafficking through the Endocytic Pathway.
Internalized cargo is transported to early endosomes. From the early or sorting
endosomes, cargo can be recycled through two different pathways. The ‘Fast’
recycling pathway requires the activity of Rab4 and Rab5, and the ‘slow’ recycling
pathway is dependent on the activity of Rab11. If a membrane protein is not recycled
at the early endosome, it is transported to late endosomes/multivesicular bodies
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(MVBs). At the MVB, a membrane protein may bud outwardly for recycling to other
cellular compartments in a Rab9 dependent manner (e.g. plasma membrane or
Golgi), or it will be internalized into the internal vesicles of the MVB for eventual
degradation upon MVB-lysosome fusion, or for secretion into the extracellular space
as exosomes upon MVB-plasma membrane fusion. To facilitate sorting of proteins
into the internal vesicles of the MVB, most protein cargo must be ubiquitinated to
enable binding by the endosomal sorting complexes required for transport (ESCRTs)
that enable protein sorting.
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1.6. Cell-Free Sorting Assay
The purpose of this study was to identify the molecular machinery that
regulates outward budding from the MVB and determine whether the machinery is
distinct from the inward budding machinery. We hypothesize that distinct
molecular mechanisms mediate inward versus outward budding from the
endosomal membrane. We used a cell-free assay that reconstitutes both
morphological formation of internalized and budded vesicles (using ultrastructural
methods) and quantitatively measures the amount of membrane protein cargo
sorted into the endosomal lumen or present on vesicles that bud from that
membrane (using biochemical methods) (Fig. 1.5).

To measure cargo

internalization, an intracellular epitope of a transmembrane cargo protein is detected
using an epitope-specific antibody (Fig. 1.5) (Sirisaengtaksin et al., 2014; Sun et al.,
2010). If the intracellular domain of the transmembrane protein is sorted into internal
MVB vesicles, it will no longer be accessible to exogenously added trypsin and is
protected from digestion, (Fig. 1.5) (Sirisaengtaksin et al., 2014; Sun et al., 2010).
Both the protease protection of a transmembrane cargo protein and the formation of
internal endosomal vesicles are dependent on cytosol, ATP, temperature, and an
intact proton gradient (Sirisaengtaksin et al., 2014; Sun et al., 2010). During the cellfree reaction, the number of internal vesicles formed, quantified by electron
microscopy, and protease protection of a membrane protein cargo (EGFR) are
correlated, suggesting that this assay measures endosomal cargo sorting and MVB
formation (Sun et al., 2010). I have modified this protease protection assay in two
important ways. First, I have shown that cytosol isolated from yeast and fly strains
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are sufficient to support the inward budding of EGFR, thus enabling the use of
genetics to examine the factors in cytosol that are required to support membrane
protein sorting and MVB formation (Chapters 3-4). Second, I have modified the
assay to capture membranes that may bud outwardly from the donor membranes
(endosomes) during the reactions (Chapter 5-7). To isolate the outwardly budded
vesicles, differential centrifugation of reaction supernatant following the 3-hour
incubation enabled me to obtain outwardly budded vesicles. Using this approach, I
have identified molecules regulating both inward and outward budding from the
MVB.
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Figure 1.5. Cell-free Reconstitution of MVB Sorting. Serum-starved cells are
stimulated to induce internalization of a membrane protein receptor from the plasma
membrane (e.g. EGFR), resulting in movement of ligand-receptor complex into
endosomes. Isolation of partially purified endosomes (1) that contain the receptor
can be detected by immunoblotting using an intracellular epitope-specific antibody.
Incubation of these endosomes with trypsin (2) removes the C-terminal epitope of
the receptor that protrudes from the plasma membrane, resulting in a loss of signal
for that epitope on an immunoblot. Incubation of endosomes with ATP and cytosol,
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at 37°C results in formation of internal vesicles and protection of the C-terminal
EGFR epitope from subsequent trypsin cleavage (3). Incubation of endosomes with
ATP and cytosol for 3 hours at 37°C [as in (3)] followed by centrifugation results in
separation of MVBs (in pellet) and outwardly budded vesicles (in supernatant). The
MVB pellet (4) is subsequently digested with trypsin while supernatant (5) is
centrifuged again to concentrate budded vesicles for collection.
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Chapter 2. Materials and Methods
2.1. Materials
Materials— Antibodies were purchased from the following commercial sources:
EGFR (Invitrogen), V5-tag (Invitrogen), c-Myc (9E10, Santa Cruz Biotechnologies),
EEA1 (Thermo Fisher), LAMP1 (H4A3 clone, Developmental Studies Hybridoma
Bank), Rab11 (Millipore), Rab 7 (Invitrogen), Transferrin Receptor (TfR) (Abcam).
Reagents were purchased form the following commercial sources: Methyl-βCyclodextrin (MβCD, Sigma), Monensin (Sigma), and soluble cholesterol (Sigma).

Constructs— The pCMV-AT1R-Myc construct was kindly provided by Dr. Guangwei
Du (UTHealth). The pcDNA3.1-hisB-V5-R4-FGFR4Gly388 construct was kindly
provided by Dr. Michael Ittmann (Baylor College of Medicine). The pcDNA-DEST40
V5-tagged Kv4 construct was kindly provided by Dr. Susan Tsunoda (Colorado State
University). The pcDNA6a myc-tagged EGFRK721A construct was kindly provided by
Dr. Mien-Chie Hung (M.D. Anderson). The PCMV-intron myc Rab11 S25N construct
was purchased from Addgene.

Cell Culture— HeLa cells (ATCC) were cultured as a monolayer in 10-cm plastic
plates in Dulbecco’s Modified Eagle Medium (DMEM, Mediatech) containing 10%
Fetal Bovine Serum (FBS, Sigma) under 5% CO2 at 37°C. Before each experiment,
cells

were

split

by

removing

them

from

the

plate

using

0.25%

trypsin/ethylenediaminetetraacetic acid (EDTA) and seeded into 10-cm tissue culture
plates. SH-SY5Y cells were cultured as a monolayer in 10-cm plastic plates in
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Roswell Park Memorial Institute (RPMI, Mediatech) containing 10% FBS and 5% Lglutamine under 5% CO2 at 37°C. Before each experiment, cells were split by
removing them from the plate using 0.25% trypsin/EDTA and seeded into 10-cm
tissue culture plates. U87 cells were cultured as a monolayer in 10-cm plastic plates
in Modified Eagle Medium (MEM, Mediatech) containing 10% FBS and 5% Nonessential amino acids (Sigma) under 5% CO2 at 37°C. Before each experiment, cells
were split by removing them from the plate using 0.05% trypsin/EDTA and seeded
into 10-cm tissue culture plates.

Recombinant proteins— Hrs and STAM were produced in insect cells as previously
described (Sirisaengtaksin et al., 2014; Tsujimoto et al., 1999).

Recombinantly

produced Dynamin 1 protein was kindly provided by Dr. Sandra L. Schmid.

2.2 Cytosol preparation
Mammalian: HeLa cells were placed on ice, washed with ice-cold PBS (2x with 5
mL), scraped from the plate, and centrifuged (2000 x g for 15 min) at 4 °C. The cell
pellet was resuspended in 100 µL of homogenization buffer (HB) (20 mM HEPES pH
7.4, 0.25 M sucrose, 2 mM EGTA, 2 mM EDTA, and 0.1 mM DTT) containing a
protease inhibitor cocktail (112 µM PMSF, 3 µM aprotinin, 112 µM leupeptin, 17 µM
pepstatin). Cells were sonicated 5 times (5 pulses of 1 second at output control 3)
(Branson Sonifier 250, VWR Scientific). The lysate was centrifuged (2000 x g for 10
min) at 4°C, and the supernatant was further centrifuged (100,000 x g for 1 hour) at
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4°C. The supernatant was collected and protein concentration was calculated using
a Bradford assay (Sirisaengtaksin et al., 2014).
Saccharomyces cerevisiae: Saccharomyces cerevisiae strains were plated on YPD
plates (500 mL ddH20 containing: 10 g bactopeptone, 5 g yeast extract, 8 g agar, 25
mL 40% dextrose) and incubated for 48 hours on a shaker at 30°C. YPD media (5
mL) was inoculated with various Saccharomyces cerevisiae strains and incubated
overnight on a shaker at 30 °C. Cultures were transferred into a secondary culture of
YPD media (50 mL) and were grown until OD600 reached 0.8-1.0. Cells were
collected (3000 x g for 3 min) and washed twice, first with 500 µL of ddH2O followed
by 500 µL TP buffer (20 mM Tris, pH 7.9; 0.5 mM EDTA; 10% glycerol; 50 mM NaCl,
112 µM leupeptin, 3 µM aproptinin, 112 µM PMSF, and 17 µM pepstatin). The cells
were recollected (3000 x g for 3 min) and resuspended into 130 µL of TP buffer.
Acid-washed beads (50 µL) were added to the cells and the cells were lysed (1 min
vortex-1 min incubation on ice, 5X). Cells were centrifuged (3000 x g for 10 min) and
the supernatant was collected. Protein concentration was calculated using a
Bradford assay. The supernatant was divided into 70 µg aliquots and stored at -80
°C. For Saccharomyces cerevisiae deletion strains (Table 1), we inoculated strains
in YPD media containing G418 (500 µg/mL).
Drosophila melanogaster: Frozen whole head homogenates of approximately 1000
fly heads were centrifuged (100,000 x g for 60 min) to pellet total membranes and
the supernatant was collected. Protein concentration was calculated using a
Bradford assay. Supernatants were stored in 25 µg aliquots at -80°C.
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2.3 Cell Transfection
Cell Transfection—Plasmid DNA was prepared (Qiagen), and HeLa cells were
transiently transfected using Lipofectamine 2000 transfection reagent according to
the manufacturer’s protocol. The constructs used in each transfection are as
indicated. Briefly, cells were plated in 6-well plates and grown until they reached 8090% confluence. In each well of the plate, DNA (3 µg) was added to Opti-MEM
reduced serum medium (250 µL), mixed, and incubated for 5 min at room
temperature. Lipofectamine 2000 reagent (3.5 µL) was added to Opti-MEM reduced
serum medium (250 µL), mixed, and incubated for 5 min at room temperature. The
tubes were combined, mixed gently, and incubated for 20 min at room temperature
before adding 500 µL to each well. After 48 hours, the cells were used in the cellfree sorting assay described below.

2.4 Cell-Free Sorting Assay
Cell-free

reconstitution

of

inward

budding

from

MVB

membranes—

The

reconstitution of inward budding was performed as described (Gireud et al., 2015;
Sirisaengtaksin et al., 2014; Sun et al., 2010). In experiments where EGFR was the
membrane protein cargo, HeLa cells were grown to 75-80% confluence. Before
harvesting, cells were serum starved (2 hours at 37°C) and stimulated with EGF
(100 ng/mL; 10 min at 37°C or 2ng/mL; 10 min at 37°C). Endosomal membranes
were isolated as previously described (Sirisaengtaksin et al., 2014; Sun et al., 2010)
and resuspended in HB buffer (volume dependent on number of reactions; 10 µL for
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control reactions and 15 µL per experimental reaction), and used for reconstitution
reactions.
Endosomal membranes (starting material) were either incubated on ice or
were trypsin-treated (6 µL of 0.27 µg/µL trypsin; 4°C for 30 minutes). For reactions
containing mammalian cytosol, a standard reaction (50 µL) contained 15 µL
endosomal membranes, 6 µL ATP regeneration system (2 mM MgATP, 50 µg/mL
creatine kinase, 8 mM phosphocreatine and 1 mM DTT of final concentrations), 25
µg of Hela cytosol and HB to a total reaction volume of 50 µL. For the
Saccharomyces cerevisiae cytosol reactions, a standard reaction (50 µL) contained
15 µL membranes, 6 µL ATP regeneration system, 70 µg of Saccharomyces
cerevisiae cytosol and HB to a total reaction volume of 50 µL. For the Drosophila
melanogaster cytosol reactions, a standard reaction (50 µL) contained 15 µL
membranes, 6 µL ATP regeneration system, 25 µg of Drosophila melanogaster (fly)
cytosol, and HB to a total reaction volume of 50 µL.
All experimental reactions were incubated for 3 hours at 37°C, followed by
trypsin-treatment (6 µl of 0.27 µg/µL trypsin; 30 min at 4°C). Experimental reactions
were centrifuged (20,000 x g; 30 min at 4°C) while control reactions remained on ice.
Control reactions were resuspended in sample buffer for SDS-PAGE. For
experimental reactions, supernatant was aspirated and pellet was resuspended in
sample buffer for biochemical examination by SDS-PAGE. Resultant blots were
probed with an antibody that recognizes amino acids1190-1210 (C-terminal epitope)
of EGFR (1:200 dilution in 5% nonfat milk with PBS, overnight at 4 °C).
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To examine the dependence of cargo sorting on the presence of ESCRT
proteins, yeast cytosol was prepared from strains listed in Table 1 and used in place
of wild-type yeast cytosol. All reactions were normalized to wild-type controls. For
the FGFR4 experiments, transfected cells were serum-starved in media containing
cycloheximide (30 µg/mL) for 2 hours and stimulated with bFGF (50 ng/mL) for 5
hours. Following the bFGF stimulation, subsequent experimental conditions were as
described for EGFR. The resulting blots were probed with an antibody that
recognized the intracellular V5-tag of FGFR4 (1:5000 dilution in 5% nonfat milk with
PBS-Tween, overnight at 4°C). For the AT1R experiments, transfected cells were
starved in serum-free media (2 hours at 37°C) and stimulated with angiotensin II (1
mg/mL) (30 minutes at 37°C). Following the angiotensin II stimulation, subsequent
experimental conditions were as described for EGFR. The blots were probed with an
antibody that recognized the intracellular Myc-tag of AT1R (1:500 dilution in 5%
nonfat milk with PBS-Tween, overnight at 4°C). For the Kv4 experiments,
transfected cells were not serum-starved or stimulated. Instead, transfected cells
were collected and partially purified endosomes isolated. Experimental conditions
were then performed as described for EGFR experiments. The blots were probed
with an antibody that recognizes the V5-tag that was fused to the COOH-terminus of
the Kv4 clone used in these studies (1:5000 dilution in 5% nonfat milk with PBSTween, overnight at 4°C). For the EGFRK721A experiments, transfected cells were
starved in serum-free media (2 hours at 37°C) and stimulated with EGF (100 ng/mL)
(10 minutes at 37°C). Experimental conditions were then performed as described for
EGFR experiments. The blots were probed with an antibody that recognized the
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intracellular Myc-tag that was fused to the COOH-terminus of the EGFRK721A clone
used in these studies EGFRK721A (1:500 dilution in 5% nonfat milk with PBS-Tween,
overnight at 4°C). For the EGFRvIII experiments, HeLa transfected cells, or U87 cells
stably expressing EGFRvIII, were serum-starved (2 hours at 37°C) and stimulated
with EGF (100 ng/mL) (10 minutes at 37°C). Experimental conditions were then
performed as described for EGFR. The resulting blots were probed with an antibody
that recognized the intracellular V5-tag that was fused to the COOH-terminus of the
EGFRvIII clone used in these studies (1:5000 dilution in 5% nonfat milk with PBSTween, overnight at 4°C).

Isolation of outwardly budding vesicles from cell-free reactions—Experimental
conditions were performed as in EGFR inward budding experiments described
above, including 70 µg of Saccharomyces cerevisiae, ATP, and the 3-hour reaction
incubation. Following the 3-hour incubation, experimental reactions were centrifuged
(20,000 x g for 30 min at 4°C). The supernatant was collected and further
centrifuged (150,000 x g for 1 hour at 4°C). After ultracentrifugation, the resulting
pellet was either resuspended in sample buffer for SDS-PAGE, or subjected to
Nanosight Tracking Analysis.

Pharmacological treatments—To examine the role of cholesterol in EGFR sorting,
crude endosomal membranes were treated with 15 mM MβCD for 15 min at 37°C.
Treated endosomal membranes were collected by centrifugation (15 min at 1500 x
G) and added into inward budding reactions (described above). Soluble cholesterol
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was added (50 µg/mL) to some reactions that also contained MβCD-treated
membranes, and incubated as described. For all drug experiments, membranes
were collected after 3 hours of incubation in assay, and analyzed as described. The
effect of monensin, a sodium ionophore that interferes with pH changes in the
endosome {Ju et al, 2004; Mesbah et al, 2011; Mora-Montes et al, 2008}, was
examined by adding either 10 µM or 60 µM monensin into experimental reactions.
Control reactions were performed using equal concentrations of the monensin
diluent, methanol.

2.5. Nanosight Tracking Analysis
NanoSight Tracking Analysis (NTA)— NTA measurements were performed on
membranes isolated from cell-free reactions in which the reaction supernatant had
been centrifuged to isolate outwardly budded vesicles using a NanoSight NS300
instrument following the manufacturer’s instructions. NTA is performed by measuring
the rate of Brownian motion of particles in a low volume light scattering system
(NanoSight Ltd., Amesbury, United Kingdom). Results are presented as mean size
of vesicles (x-axis) and concentration of particles per mL of solution (y-axis).
Samples were examined in triplicate.

2.6. Electron Microscopy
Electron Microscopy (EM)— Vesicle size was visualized using TEM on membranes
isolated from supernatant obtained from MVB sorting reactions. 5 µL of vesicles
were placed on glow discharged carbon formvar grids (TedPella) for approximately 5
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min. Grids were rinsed 3x with 5 µL of water, using blotting paper to wick away
excess liquid between rinses. Finally, grids were rinsed quickly with 50% mixture of
NanoW (Nanoprobes) stain, wicked, and then stained for approximately 30 min
before wicking excess liquid and allowing grids to dry for at least 30 min prior to
imaging. Micrographs were collected on a JOEL 1400 electron microscope operated
at 120 kV using a Gatan ultrascan camera.

2.7. Mass Spectrometry
Mass spectrometry (MS)— Membranes isolated from supernatant obtained from
MVB sorting reactions were isolated for biochemical examination by SDS-PAGE as
described above. Following gel electrophoresis, gels were stained with coomassie
blue. Gel slices were submitted to the Taplin Mass Spectrometry Facility at Harvard
Medical School for analysis.

2.8. OptiPrep Gradient
OptiPrep Gradient— After HeLa cells were serum-starved and stimulated (100
ng/mL EGF; 20 min at 37°C), post-nuclear supernatant was isolated and loaded on
top of a continuous Opti-prep gradient (Sigma, 10-20%) and centrifuged (150,000 x
g for 10 hours at 4°C) in a swinging bucket rotor (TLS 55, Beckman). Fractions (200
µL) were collected and diluted in of HB (200 µL) followed by centrifugation (150,000
x g for 1 hour at 4°C). The resulting pellet was resuspended in sample buffer for
biochemical examination. If the fractions were to be used in the cell-free assay,
fractions 3 & 4 containing late endosomal membranes were collected and fractions 8
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& 9 containing early endosomal membranes were collected and diluted in HB (400
uL) followed by centrifugation (150,000 x g for 1 hour at 4°C). The resulting pellets
were resuspended in HB and membranes were used in cell-free reactions.

2.9. Generation of yeast double knock out strains
Generation of Saccharomyces cerevisiae heterozygous double knock out strains—
Conversion

of

(Dharmacon:
did4::KANMX6

snf7::KANMX6

and

did4::KANMX6

strains:

snf7::KANMX6

MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 snf7Δ::KANMX6) and
(Dharmacon:

MATa

his3Δ1

leu2Δ0

ura3Δ0

met15Δ0

did4Δ::KANMX6) strains were transformed as previously described (Gietz and
Woods) with SalI-ClaI digested plasmid pAG32 (HPHMX6) (Goldstein and
McCusker, 1999). Briefly, cells were grown in 5 mL of YPD and incubated (overnight
at 30°C). The next day, cells were re-inoculated in 20 mL of YPD at a starting OD600
of 0.2. Once cells had reached a final OD600 of 0.8, they were collected (1000 x g for
5 minutes) and washed in 500 µL of 100 mM LiAc. The cell suspension was then
collected (1000 x g for 5 minutes) and resuspended in transformation solution (50%
PEG, 0.1M LiAc, 10 µg carrier DNA, ddH2O) and 1 µg of digested pAG32. Cells
were incubated for 30 minutes at 30 °C followed by incubation at 42 °C for 20
minutes. Next, cells were collected (3300 x g for 15 seconds), resuspended in 100
µL of ddH20 and plated on YPD plates containing 500 µg/mL Hygromycin B.
Tranformants were selected based on sensitivity to G418 and resistance to
Hygromycin B. The resulting strains were yMG1 and yMG2 (see Table 1).
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Creation of heterozygous double knock out strains: To create the snf7 vps20 and
did4 vps24 strains, the yMG1 and yMG2 strains were crossed with the vsp20Δ and
vps24Δ strains, respectively. G418R Hygromycin BR heterozygous diploid knock out
strains were selected for further studies.

2.10. Statistical Analysis
Statistical Analysis— Statistical significance was determined using either a Paired ttest or one-way ANOVA for independent samples and post-hoc analysis (Tukey
test). All data were tested for normality using the Shapiro-Wilk test prior to analysis.
A p-value of <0.05 was considered statistically significant with an n=>3.
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Chapter 3. Mechanisms of Inward Budding
Rationale: Membrane proteins that move from the limiting membrane into internal
vesicles of MVBs may be degraded upon MVB-lysosome fusion. The process of
protein movement into internal vesicles is thought to involve protein aggregation on
the membrane to sort the proteins to be internalized into a domain of the membrane,
followed by invagination of that part of the membrane and fission of the invaginated
membrane resulting in formation of an internal vesicle. Using our cell free assay
(described in Chapter 1 and Figure 1.6), I can measure internal vesicle formation
and movement of cargo proteins from the limiting endosomal membrane into internal
vesicles.
3.1. Saccharomyces cerevisiae (yeast) and Drosophila melanogaster (fly) cytosol
are sufficient to support the mammalian endosomal sorting of the EGFR.
To determine whether yeast or fly cytosol could substitute for cytosol obtained
from mammalian sources in our cell-free assay (Fig. 1.3) (Sirisaengtaksin et al.,
2014; Sun et al., 2010), reactions were incubated with mammalian, yeast, or fly
cytosol. The efficiency of the cell-free reactions as judged by the EGFR protected
from protease cleavage after the cell-free reactions using yeast and fly cytosol was
24+/-7% and 32+/-1%, respectively, compared to what I observed with mammalian
cytosol, 48+/-9% (Fig. 3.1a). These data suggest that while quantitative differences
exist between the mammalian, yeast, and fly systems, all three systems contain
essential proteins required for the inward budding event.
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Figure 3.1 Cytosol isolated from HeLa cells, Saccharomyces cerevisiae,
and Drosophila melanogaster support the protease protection of EGFR.
Partially purified HeLa endosomal membranes containing EGFR were isolated. (a-c)
Endosomal membranes (5 µL, lane 1) and endosomal membranes (5 µL) digested
with trypsin to remove the C-terminal epitope of the receptor (lane 2), as well as
partially purified HeLa endosomal membranes (15 µL) that had been incubated in
reactions containing ATP and cytosol derived from: HeLa cells (25 µg, a),
Saccharomyces cerevisiae (70 µg, b), or Drosophila melanogaster (25 µg, c), at
37°C prior to trypsin treatment (lane 3) are shown. Data represents the mean +/S.E. (n=3) normalized to membrane control.
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3.2 The protease protection of EGFR, or inward budding, is dependent on ESCRT
proteins.
To examine whether ESCRT proteins (Bache et al., 2003; Futter et al., 1996;
Hurley and Emr, 2006; Katzmann et al.; Lemmon and Traub; Saksena et al., 2007;
Sun et al., 2010) are required for inward budding, measured by protease protection
of the EGFR intracellular epitope, cytosol derived from yeast strains deleted of
ESCRT proteins (Table 1) was used in cell-free reactions in place of wild-type yeast
cytosol. Reactions containing cytosol derived from ESCRT-0 deficient yeast strains
(vps27Δ, hse1Δ) decreased EGFR epitope protease protection (Fig. 3.2a). If I added
recombinant mammalian ESCRT-0 homologs (Hrs and STAM, 8µg) into reactions
that include cytosol isolated from vps27Δ or hse1Δ strains, the inhibition of inward
budding was rescued (Fig. 3.2b, 3.2c). Thus, deletion of individual ESCRT-0
components decreased inward budding of EGFR into internal endosomal vesicles,
an effect that was rescued by addition of exogenous orthologous mammalian
recombinant proteins.
Deletion of ESCRT-I, ESCRT-II, or ESCRT-III decrease MVB internal vesicle
formation and result in impaired MVB biogenesis (Bilodeau et al., 2002; Hurley and
Hanson, 2010; Schmidt and Teis). To determine whether we are able to reproduce
the ESCRT-dependence of inward endosomal budding and cargo sorting in our
assay, cytosol isolated from yeast strains deleted of ESCRT genes (Table 1) was
used in place of cytosol isolated from the parental strain. Cytosol derived from
ESCRT-I deficient yeast strains (vps23Δ, vps28Δ, vps37Δ, or mvb12Δ) or ESCRT-II
deficient yeast strains (vps36Δ, snf8Δ, vps25Δ) significantly decreased the protease
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protection of the EGFR epitope (Fig. 3.3a and Fig. 3.3b respectively), suggesting
that ESCRT-I and ESCRT-II components are required for inward endosomal
membrane budding.
I observed that protease protection of the EGFR is dependent on Vps4 as
well as the ESCRT-III components Snf7 and Vps24 (Fig. 3.3c, lanes 4, 5, 7).
However, cytosol derived from yeast strains deficient in the ESCRT-III genes,
VPS20 and DID4, did not significantly impair protease protection of the EGFR (Fig.
3.3c, lanes 3, 6). Haplo-insufficient yeast strains of the two major ESCRT-III
complexes (Snf7/Vps20 and Vps24/DID4, yMG3 and yMG4, respectively) were
generated to determine whether the components of these complexes might have
overlapping or redundant roles (Table 1). Cytosol derived from yMG3 and yMG4
yeast strains significantly decreased the protease protection of the EGFR epitope
compared to cytosol isolated from parental strains (Fig. 3.3c, lanes 8-9 compared to
lane 1). However, the effect of yMG3 (47+/-5%) compared to the Snf7 single deletion
strains (44+/-12%), or yMG4 (55+/-1%) compared to the Vps24 single deletion
strains (51+/-12%), on the protease protection of the EGFR epitope was not
significantly different (Fig. 3.3c, Lane 8 compared to lane 4, and lane 9 compared to
lane 5). The cytosol isolated from ESCRT-III double deletion strains appears
additive, suggesting that Vps20 and Did4 are not required for inward budding and
that Snf7 and Vps24 are sufficient to support inward budding of the EGFR.
.
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Name

Genotype

vps27Δ
hse1Δ
vps23Δ
vps28Δ
vps37Δ
mvb12aΔ
vps36Δ
snf8Δ
vps25Δ
snf7Δ
did4Δ
vps20Δ
vps24Δ
yMG1
yMG2
yMG3

yMG4

MATa
his3Δ1
leu2Δ0
ura3Δ0
met15Δ0
vps27::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
met15Δ0
hse::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
lys2Δ0
vps23::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
lys2Δ0
vps28::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
met15Δ0
vps37::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
met15Δ0
mvb12a::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
lys2Δ0
vps36::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
lys2Δ0
snf8::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
lys2Δ0
vps25::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
met15Δ0
snf7::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
met15Δ0
did4::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
lys2Δ0
vps20::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
lys2Δ0
vps24::KANMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
met15Δ0
snf7::HPHMX6
MATa
his3Δ1
leu2Δ0
ura3Δ0
met15Δ0
did4::HPHMX6
MATa/MATα his3Δ1/ his3Δ1 leu2Δ0/leu2Δ0
ura3Δ0/ura3Δ0 MET15/met15Δ0 LYS2/lys2Δ0
SNF7/snf7::HPHMX6 VPS20/vps20::KANMX6

Source
Reference

or

Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
This study
This study
This study

MATa/MATα his3Δ1/ his3Δ1 leu2Δ0/leu2Δ0
ura3Δ0/ura3Δ0 MET15/met15Δ0 LYS2/lys2Δ0 This study
DID4/did4::HPHMX6 VPS24/vps24::KANMX6

Table 1: Saccharomyces cerevisiae strains used in this study. Yeast
strains were kindly provided by Dr. Kevin Morano but are commercially available.
Yeast strains yMG1-yMG4 were generated for use in this study.
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Figure 3.2. ESCRT-0 proteins are required for inward budding of EGFR.
Partially purified HeLa endosomal membranes were isolated as described in Fig.
1.6. a) Reactions incubated with cytosol isolated from ESCRT-0 deficient yeast
strains (vps27Δ, hse1Δ) significantly decrease protease protection of EGFR
compared to cytosol isolated from a parental strain (Lane 2 and 3 compared to lane
1). b) Recombinant human Hrs rescues the inhibition of EGFR protease protection
(b, lane 3). c) Recombinant human STAM rescues the inhibition of EGFR protease
protection (c, lane 3). Data represents the mean +/- S.E (n=3) normalized to the
wild-type control. *Denotes P<0.05.
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Figure 3.3: ESCRT proteins are required for inward budding of EGFR. Partially
purified HeLa endosomal membranes were isolated as described in Fig. 1.6. a)
Reactions incubated with cytosol isolated from ESCRT-I deficient yeast strains
(vps23Δ, vps28Δ, vps37Δ, mvb12Δ) significantly inhibit EGFR protease protection
(lanes 2-5) compared to cytosol isolated from a parental strain (lane 1). b) Reactions
incubated with cytosol isolated from ESCRT-II deficient yeast strains (vps25Δ,
snf8Δ, vps36Δ) significantly inhibit EGFR protease protection (lanes 2-4) compared
to cytosol isolated from a parental strain (lane 1). c) Reactions incubated with
cytosol isolated from yeast strains deleted of the ESCRT-III genes (snf7Δ, vps24Δ)
or the AAA ATPase VPS4 gene (vps4Δ) significantly inhibit EGFR protease
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protection (lanes 4, 5, 7), compared to cytosol isolated from a parental strain (lane
1). Reactions incubated with cytosol isolated from vps20Δ or did4Δ strains prior to
trypsin treatment, did not alter EGFR protease protection (lane 3, 6), compared to
cytosol isolated from a parental strain (lane 1). Cytosol isolated from the yeast strain
deficient of HSE1 was used as a control in these experiments (lane 2). Reactions
incubated with cytosol isolated from ESCRT-III haplo-insufficient yeast strains
(yMG3 and yMG4) significantly inhibit EGFR protease protection compared to
cytosol isolated from a parental strain (lanes 8-9). However, the EGFR protected
was not significantly different from the single deletion strains (lane 4-5). Data
represents the mean +/- S.E (n=3) normalized to the wild-type control. *Denotes
P<0.05 (t-test for a, d-f; Anova for b,c).
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3.3. Vps1 and Vps21 do not affect EGFR sorting.
Control experiments were performed using cytosol derived from yeast strains
in which non-ESCRT cytosolic proteins were deleted. Cytosol from yeast strains in
which Vps1, a dynamin-like yeast homolog, or Vps21, the yeast homolog of Rab5,
were deleted and were examined in our cell-free assay. Neither Vps1 nor Vps21
have been implicated in MVB biogenesis and cytosol from yeast strains in which
Vps1 or Vps21 were deleted resulted in no significant alteration in protease
protection of the EGFR (Fig 3.4).
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Figure 3.4: Deletion of VPS1 and VPS21 genes does not impair EGFR sorting.
Partially purified HeLa endosomal membranes were isolated as described in Fig.
1.6.

a) Endosomes incubated with cytosol derived from yeast strains that are

deficient of the genes VPS1 or VPS21 did not alter the protease protection of EGFR
compared to cytosol isolated from a parental strain (lanes 2 and 3 compared to lane
1). Cytosol isolated from hse1Δ strains was used as a control in these experiments
(lane 4). Data represents the mean +/- S.E (n=3) normalized to control. *denotes p <
0.05.
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3.4. Cholesterol is required for inward budding of EGFR at MVBs.
Cholesterol is enriched in lipid rafts and lipid rafts have been implicated in
various membrane budding events (Babst, 2011; Bissig and Gruenberg, 2013).
Moreover, cholesterol is concentrated on internal MVB vesicles (Mobius et al., 2003)
suggesting that cholesterol may play a role in inward budding events at the MVB. To
determine whether cholesterol is required for MVB sorting of transmembrane cargo,
endosomes were depleted of cholesterol using Methly-β CycloDextrin (MβCD).
Endosomal membranes treated with 15 mM MβCD had significantly decreased
sorting of EGFR into internal vesicles compared with vehicle treated cells (Fig. 3.5,
lane 2 compared to lane 1). The inhibition of EGFR protease protection in MβCDtreated endosomes was rescued by the addition of soluble cholesterol (Fig. 3.5, lane
3), whereas soluble cholesterol had no effect on EGFR protease protection (Fig 3.5,
lane 4). These data suggest that cholesterol is required for protease protection of
EGFR and imply that inward vesicle budding is dependent on the availability of
cholesterol in the endosomal membrane.
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Figure 3.5: Cholesterol is required for EGFR sorting at the MVB. Partially
purified HeLa endosomal membranes were isolated as described in Fig. 1.6.
Endosomal treatment with MβCD decreased protease protection of EGFR (lanes 2)
compared to vehicle control (lane 1). Soluble cholesterol rescues the inhibition of
EGFR protease protection (lane 3). Soluble cholesterol had no effect on its own
(lane 4). Data represents the mean +/- S.E (n=3) normalized to the control. *denotes
P<0.05. These experiments were performed by Sahily Reyes and used with
permission.
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3.5. Inward budding of EGFR is dependent on pH at MVBs.
Previous studies from our laboratory reported that when the ionophore
nigericin was incubated in cell-free reactions protease protection of the EGFR was
inhibited, suggesting that intra-endosomal pH is an important factor in inward
budding (Sun et al., 2010). We examined whether the ionophore monensin would
inhibit protease protection of the EGFR. Partially purified endosomes were isolated
and incubated with either vehicle or Monensin (10 µM or 60 µM), ATP and cytosol
for 3 hours at 37°C. Significant inhibition of EGFR protease protection was observed
in reactions incubated with 60 µM Monensin (Fig. 3.6, lane 3 compared to lane 1 and
lane 4) compared to vehicle control. A lower concentration of Monensin, 10 µM, had
no significant effect on EGFR sorting (lane 2 compared to lane 1 and lane 4). These
data suggest that intra-endosomal pH regulates endosomal sorting.
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Figure 3.6. EGFR sorting into internal vesicles is dependent on pH. Partially
purified HeLa endosomal membranes were isolated as described in Fig. 1.6.
Endosomes incubated with 60 µM Monensin decreased protease protection of
EGFR (lane 3) compared to vehicle controls (lane 1 and 4). Endosomes incubated
with 10 µM Monensin (lane 2) had no effect on protease protection of EGFR
compared to vehicle controls (lane 1 and 4). Data represents the mean +/- S.E (n=3)
normalized to the control. *denotes P<0.05. These experiments were performed by
Sahily Reyes and used with permission.
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Chapter

4.

Different

types

of

cargo

proteins

are

internalized into MVBs in an ESCRT-dependent manner
Rationale: For the majority of my experiments, EGFR was used as a proxy for
transmembrane cargo proteins that are internalized and pass through the endocytic
pathway prior to degradation in the lysosome. I considered the possibility that our
reaction conditions are specific for EGFR movement from the endosomal membrane
but may not reflect a variety of membrane proteins thought to transit this pathway en
route to lysosomes. To determine whether our assay may be generally applicable to
understanding trafficking of membrane proteins in the late endocytic pathway I
examined the movement of other types of membrane proteins from the endosomal
membrane.

4.1. FGFR4 is sorted into MVBs in an ESCRT-dependent manner.
To determine whether other single pass transmembrane proteins can be
examined using our approach, we determined whether protease protection of the
Fibroblast Growth Factor Receptor 4 (FGFR4) would occur during our cell-free
reaction. I observed that under our assay conditions, the intracellular epitope of
FGFR4 was protected from protease cleavage, suggesting that during the cell-free
reactions FGFR4 budded inwardly into internal vesicles of MVBs (Fig. 4.1a). Cytosol
derived from a yeast strain deficient in the ESCRT-0 component, HSE1, significantly
decreased the FGFR4 protease protection compared to reactions containing
parental yeast cytosol (Fig. 4.1b, lane 1). These data suggest that FGFR4
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undergoes ESCRT-dependent transport into MVB internal vesicles and imply that
FGFR4 follows the canonical MVB degradation pathway to the lysosome.

Figure 4.1. FGFR4 is sorted into MVBs in an ESCRT-dependent manner. HeLa
cells were transfected with an FGFR4 construct containing a C-terminal V5 epitope
tag. Partially purified HeLa endosomal membranes were isolated as described in
Fig. 1.6. a) FGFR4 containing endosomes incubated with mammalian cytosol (25
µg) result in the protease protection of the FGFR4. b) Endosomes incubated with
cytosol isolated from hse1Δ strains significantly decrease protease protection of
FGFR4 (lane 2) compared to cytosol isolated from a parental strain (lane 1). Data
represents the mean +/- S.E (n=3) normalized to the control. *denotes P<0.05.
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4.2. AT1R is sorted into MVBs in an ESCRT-dependent manner.
I next examined whether the endosomal internalization of a G-protein coupled
receptor, the Angiotensin II Type 1 Receptor (AT1R) could be measured in the
protease protection assay. AT1R is thought to enter MVBs prior to lysosomal
degradation (Hunyady et al., 2002). An intracellular epitope of AT1R was protected
from protease cleavage during our cell-free reaction suggesting that during the
reaction the AT1R buds inwardly into internal vesicles of MVBs (Fig. 4.2a). Cytosol
derived from a yeast strain deficient in HSE1 significantly decreased protease
protection of the AT1R compared to reactions containing parental yeast cytosol (Fig.
4.2b). These data suggest that the AT1R requires ESCRT protein sorting on
endosomal membranes and can be internalized into MVB luminal vesicles.
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Figure 4.2. AT1R is sorted into MVBs in an ESCRT-dependent manner. HeLa
cells were transfected with an AT1R construct containing a C-terminal myc epitope
tag. Partially purified HeLa endosomal membranes were isolated as described in
Fig. 1.6.a) AT1R containing endosomes incubated with mammalian cytosol (25 µg)
result in the protease protection of the AT1R. b) Endosomes incubated with cytosol
isolated from hse1Δ strains significantly decrease protease protection of AT1R (lane
2) compared to cytosol isolated from a parental strain (lane 1). Data represents the
mean +/- S.E (n=3) normalized to the control. *denotes p < 0.05 (t-test). These
experiments were performed in part by Kimiya Memarzadeh and used with
permission.
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4.3. Kv4 is sorted into MVBs.
Ion channels are another category of membrane protein that signal when
present on the plasma membrane and are degraded in the lysosome (Abriel and
Staub, 2005; Staub et al., 1997). To examine the endosomal trafficking of the
neuronal A-type potassium channel Kv4 (Ping et al., 2015) SH-SY5Y neuronal cells
were transfected with V5 epitope-tagged Kv4. The intracellular epitope of Kv4 is
protected from protease cleavage during the cell-free reaction, suggesting that Kv4
can bud inwardly into MVB internal vesicles (Fig. 4.3). These data suggest that the
Kv4 channel transits through the MVB during its endosomal trafficking route and that
endosomal trafficking of multiple categories of membrane proteins can be examined
under cell-free conditions.
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Figure 4.3. Kv4 is sorted into MVBs. SH-SY5Y cells were transfected with Kv4
constructs containing a C-terminal V5 epitope tag. Partially purified SH-SY5Y
endosomal membranes were isolated as described in Fig. 1.6. Kv4 containing
endosomes incubated with mammalian cytosol (25 µg) result in the protease
protection of the Kv4. Data represents the mean +/- S.E (n=3) normalized to the
control.
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Chapter 5. Characterization of outwardly budded vesicles
from MVBs

Rationale: Cargo that is not sorted into regions of the endosomal membrane that
invaginate and bud inwardly forming internal MVB vesicles can remain on the
limiting endosomal membrane for incorporation into the lysosomal membrane upon
MVB-lysosome fusion.

Alternatively, membrane proteins may bud outwardly on

vesicles that would enable transport to other cellular compartments, a mechanism
that could limit cargo accumulation on the MVB limiting membrane (Adell and Teis;
Babst, 2011; Baumgart et al., 2007; Hurley and Hanson, 2010), and ensure
consistent MVB size (Babst, 2011; Hurley and Hanson, 2010). However, these
hypothesized

transport

vesicles

have

never

been

isolated

and

therefore

requirements for this budding reaction are unknown. I modified our cell-free assay to
attempt to isolate vesicles that may bud outwardly from MVBs to characterize these
vesicles and elucidate the requirements for this budding step.
5.1. Isolation and characterization of vesicles that bud outwardly from the MVB
compartment.
To isolate the outwardly budded vesicles, partially purified endosomes were
isolated as previously described in Figure 1.6 (Gireud et al., 2015; Sun et al., 2010;
Sirisaengtaksin et al., 2014) and incubated with ATP and Saccharomyces cerevisiae
(70 µg) cytosol for 3 hours at 37°C. Following the 3-hour incubation, experimental
reactions were centrifuged and the resulting supernatant was collected for additional
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high speed centrifugation to obtain outwardly budded vesicles. I isolated vesicles
that are liberated from the endosomal membrane during our cell-free reactions (Fig.
5.1). The outward budding of vesicles in our reactions is dependent on cytosolic
factors (Fig. 5.1c, lane 2 compared to lane 1). I characterized this vesicle population
using light scattering and Brownian motion analysis (Nanosight Tracking Analysis),
electron microscopy, immunoblotting and mass spectrometry. NTA analysis revealed
that vesicles recovered from cell-free reaction supernatant were found in a major
peak with a hydrodynamic diameter of 118+/-13.6 nm (Fig. 5.1a). When the isolated
vesicles were visualized using electron microscopy they were approximately 100 nm
in size (Fig. 5.1b). In addition, the isolated vesicles were immunoreactive for EGFR
(Fig 5.1c). The percentage of total EGFR recovered in the outwardly budded
vesicles is 6.5+/-1.5% (Fig. 5.1c) compared to 39+/-7% of total EGFR that is
protected from protease cleavage (inwardly budded) (Fig. 5.1c). The intracellular
epitope of the EGFR was cleaved from isolated outwardly budded vesicles by trypsin
incubation (Fig. 5.1d, lane 2 compared to lane 1), confirming that the tail domain of
the EGFR is present on the outside of isolated vesicles as would be expected from
vesicles that have budded outwardly from the endosomal limiting membrane. Mass
Spectrometry analysis of proteins found on the isolated outwardly budded vesicles
revealed proteins associated with these vesicles that have previously been
implicated in protein trafficking (see Table 2), including adaptor proteins, Rab
proteins, coat proteins, retromer proteins, SNAREs, sorting nexins, and large
GTPases (see Table 2). My studies are the first to isolate and identify the cargo
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constituents of the transport vesicles from the MVB, and will enable identification of
the molecular mechanisms regulating outward budding from the MVB.
5.2. A subset of the outwardly budding vesicles may be targeted to the plasma
membrane.
An EGFR mutant lacking kinase activity, EGFRK721A, is internalized from the
plasma membrane and is transported to the limiting membranes of MVBs prior to
budding outwardly into vesicles, some of which reach the plasma membrane (Felder
et al., 1990). I examined whether EGFRK721A is found in outwardly budded vesicles
isolated from our cell-free assay. I found that 5+/-1.3% of the total EGFR K721A is
recovered in the isolated vesicles (Fig. 5.2) and 19+/-4.8% of total EGFR K721A is
protected from trypsin digestion (inwardly budded) (Fig. 5.2). These data suggest
that some of the outwardly budding vesicles I isolate from the cell-free reactions may
be targeted to the plasma membrane.
5.3. Differential amounts of EGF do not alter EGFR trafficking.
The trafficking of EGFR can vary under different ligand stimulation conditions
(Harris et al., 2003; Henriksen et al., 2013; Sigismund et al., 2008; Wilson et al.,
2012). For example, low EGF stimulation results in internalization through clathrinmediated endocytosis and decreased degradation of EGFR whereas high EGF
stimulation results in internalization through clathrin-mediated endocytosis or
clathrin-independent endocytosis and enhances EGFR degradation (Sigismund et
al., 2008). I examined whether the amount of EGFR found in inwardly and outwardly
budded vesicles was different under different stimulation conditions (Fig. 5.3). When
stimulated with low EGF concentrations (2ng/ml) conditions, 2+/-0.2% of EGFR is
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found in the outwardly budded vesicles (Fig. 5.3, lane 1) and 20+/-6.3% of EGFR is
protected from trypsin digestion (inwardly budding) (Fig. 5.3, lane 3). Following high
EGF stimulation (100ng) conditions, approximately 6+/-1.7% of EGFR is found in the
outwardly budded vesicles (lane 2) and 35+/-4.3% of EGFR is protected from
protease cleavage (inwardly budded) (lane 4). While there was a trend towards an
increase in the outward budding:inward budding ratio, there is no significant
difference between EGFR disposition under low or high EGF stimulation conditions
(9.7% and 16.2%), respectively. These data suggest that the trafficking of EGFR at
the MVB is similar under different stimulation conditions and perhaps the differences
in internalization of EGFR may affect EGFR trafficking during early parts of the
endocytic pathway.
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Figure 5.1: Isolation and characterization of outwardly budded vesicles from
endosomal membranes. Outwardly budded vesicles were isolated as described in
Fig. 1.6. a) Nanosight tracking analysis revealed the vesicles were 118+/-13.6 nm in
size. b) Vesicles visualized using electron microscopy were approximately 100 nm in
size. Scale bar = 100 nm. c) The amount of EGFR found in the budded vesicles is
6.5+/-1.5% of the total added into the reactions (c, lane 1). The percentage of EGFR
that is protease protected (internalized) is 39+/-7% (c, lane 3). Both outward budding
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and inward budding are dependent on cytosolic components (c, lane 2 compared to
lane 1, and lane 4 compared to lane 3). d) The intracellular epitope of the EGFR was
cleaved from isolated outwardly budded vesicles by trypsin incubation. Data
represents the mean +/- S.E (n=3) normalized to the control. *denotes P<0.05. NTA
analysis was performed in part by Shinji Yamashita and used with permission. The
EM experiments were performed in part by Madeline Farley and used with
permission.
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Endosomal

Vesicles.

Mass

Spectrometry analysis reveals multiple types of protein classes associated with
outwardly budded vesicles. Gene name, protein name, reference, molecular weight,
and average are listed (n=2).
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Fig. 5.2. A subset of outwardly budded endosomal vesicles may target the
plasma membrane. HeLa cells were transfected with EGFRK721A containing a Cterminal myc epitope tag. Outwardly budded vesicles were isolated as described in
Fig. 1.6. Outwardly budding vesicles containing EGFRK721A were 5+/-1.3% of total
EGFRK721A isolated following the cell-free reaction (e, lane 1) whereas 19+/-4.8% of
total EGFR K721A is protected from trypsin digestion (e, lane 2). Data represents the
mean +/- S.E (n=3) normalized to the control. *denotes p < 0.05 (t-test).
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Figure 5.3. Varying EGF stimulation does not alter endosomal EGFR
trafficking. Outwardly budded vesicles were isolated as described in Fig. 1.6. a)
Stimulation with low concentrations of EGF (2ng/ml) revealed that 2+/-0.2% of EGFR
is found in outwardly budded vesicles (lane 1) while 20+/-6.3% of EGFR is protected
from protease digestion (lane 3). Stimulation with high concentrations of EGF
(100ng/ml) revealed that 6+/-1.7% % of EGFR is found in outwardly budded vesicles
(lane 2) while 35+/-4.3% of EGFR is protected from trypsin digestion (inwardly
budded) (lane 4). b) The ratio between outwardly and inwardly budded vesicles
under different stimulation conditions is not significantly different. Data represents
the mean +/- S.E (n=3) normalized to the control. *denotes p < 0.05.
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Chapter 6. Mechanisms of outward vesicle budding from
MVBs.
Rationale: My results show that outward budding from MVBs is dependent on
cytosolic components (Fig. 5.1c). However, the cytosolic molecules that regulate
outward budding from MVBs have not been elucidated. I have taken both candidate
and genetic approaches to discover cytosolic factors required for this budding event.
6.1. Distinct molecular machineries regulate outward vesicle budding and inward
vesicle budding.
To identify factors that may play a role in outward budding, I isolated cytosol
from yeast strains lacking various genes. To examine whether ESCRT proteins may
play a role in outward vesicle budding, cytosol derived from a yeast strain lacking
HSE1 (hse1Δ) was used in place of cytosol isolated from a parental yeast strain in
our cell-free assay. Interestingly, EGFR immunoreactivity is significantly increased in
outwardly budded vesicles that were isolated from hse1Δ reaction supernatant
compared to cytosol isolated from the parental strain (Fig. 6.1a, lane 2 compared to
lane 1). The EGFR was less protected from protease cleavage in reactions
containing hse1Δ cytosol compared to its protease protection in reactions containing
cytosol isolated from parental strains (Fig. 6.1b, lane 2 compared to lane 1). Thus,
while the ESCRT proteins do not appear to be required for outward vesicle budding,
inhibition of inward budding by deleting HSE1 results in increased outward budding,
suggesting that inward and outward budding are linked processes.
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To interrogate the cytosol further, I screened cytosol isolated from yeast
deletion mutants for its ability to support outward budding. Interestingly, cytosol
derived from a yeast strain deficient in a dynamin-like yeast ortholog, VPS1 (vps1Δ
cytosol), inhibited the amount of EGFR-immunoreactivity in isolated vesicles
compared to cytosol isolated from the parental strain (Fig. 6.2a, lane 2 compared to
lane 1). Vps1Δ cytosol had no significant effect on the protease protection of EGFR
(Fig. 6.2b) suggesting that inward budding was not altered in the absence of VPS1.
Rescue experiments in which I added recombinant mammalian Dynamin1 to
reactions containing vps1Δ cytosol, rescued the inhibition of outward budding (Fig.
6.2a, lane 3 compared to lane 2). These data suggest that dynamin is required for
outward budding of EGFR, but not inward budding into internal MVB vesicles.
Aside from dynamin, I identified multiple GTPases that are associated with
outwardly budded vesicles isolated from our cell-free reaction supernatant (Table 2).
GTPases have been implicated in multiple membrane budding events (Nicoziani and
van Deurs, 2000; Stenmark 2009; Traub, 2010; Grant and Donaldson, 2009;
Maxfield and McGraw, 2004; Thompson et al., 2007; Weigert et al., 2004;
Kobayashi, 2013; McCaffrey and Bucci, 2001; Yamashiro and Maxfield, 1984;
Hopkins and Trowbridge, 1994; Ghosh and Maxfield, 1995).

In this regard, the

GTPase, Rab11 regulates outward budding from early endosomes (Kobayashi and
Fukuda, 2013; van Dam and Stoorvogel, 2002). However, Rab11 or Transferrin
Receptor (TfR, which is known to traffic in Rab11 compartments) were not detected
on vesicles isolated from our reaction supernatant suggesting that Rab11 does not
play a role in outward budding from MVBs. Nevertheless, I expressed dominant-
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negative Rab11 (Rab11S25N) (Fig. 6.3c) in cells and examined whether its
expression would affect outward vesicle budding from MVBs. EGFR immunopositive
outwardly budded vesicles were isolated from reactions and there was no significant
difference in EGFR levels observed in reaction supernatant when cells expressed
Rab11S25N (Fig 6.3a, lane 1), suggesting that Rab11 is not required for EGFRpositive outwardly budded vesicles. As I previously observed (Fig. 6.1) reactions
containing cytosol isolated from an ESCRT-0 deficient yeast strain (hse1Δ)
produced significantly higher levels of EGFR-immunoreactivitiy in the reaction
supernatant compared to cytosol isolated from a parental yeast strain (Fig. 6.3a,
lane 2 compared to lane 1). By contrast, decreased EGFR-immunoreactivity in
reaction supernatant (outwardly budded vesicles) was observed in reactions
containing dynamin-deficient (vps1Δ) cytosol (Fig. 6.3b, lane 3 compared to lane 1)
compared to control in cells expressing Rab11S25N.
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Figure 6.1. Deletion of ESCRT machinery increases outward vesicle budding.
Outwardly budded vesicles were isolated as in Figure 1.6. a) Vesicles isolated from
hse1Δ reaction supernatant significantly increase EGFR immunoreactivity compared
to cytosol isolated from a parental strain (lane 2, compared to lane 1). b) Reactions
incubated with cytosol isolated from hse1Δ strains significantly inhibit protease
protection of EGFR compared to cytosol isolated from parental strains (lane 2
compared to 1). Data represents the mean +/- S.E (n=3) normalized to the control.
*denotes p < 0.05.
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Figure 6.2. Dynamin is required for outward vesicle budding. Outwardly budded
vesicles were isolated as in Figure 1.6. a) Vesicles isolated from vps1Δ reaction
supernatant significantly decrease EGFR immunoreactivity compared to cytosol
isolated from a parental strain (lane 2 compared to lane 1). Recombinant human
dynamin1 (1µm) rescues the inhibition of EGFR immunoreactivity (lane 3 compared
to lane 1). b) Reactions incubated with cytosol isolated from vps1Δ strains or vps1Δ
strains plus dynamin1 did not alter protease protection of EGFR compared to cytosol
isolated from a parental strain (lane 2 and 3 compared to lane 1). Data represents
the mean +/- S.E (n=3) normalized to the control. *denotes p < 0.05 (t-test for a,b;
ANOVA for c,d).
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Figure 6.3. EGFR buds outwardly from endosomal membranes in a Rab11
independent manner. HeLa cells were transfected with a dominant negative Rab11
(Rab11S25N) construct containing a C-terminal myc epitope tag. Outwardly budded
vesicles were isolated as in Figure 1b. a) Vesicles isolated from hse1Δ reaction
supernatant significantly increase EGFR immunoreactivity compared to cytosol
isolated from a parental strain (lane 2, compared to lane 1). Vesicles isolated from
vps1Δ

reaction

supernatant

significantly

decrease

EGFR

immunoreactivity

compared to cytosol isolated from a parental strain (lane 2 compared to lane 1). b)
Reactions incubated with cytosol isolated from hse1Δ strains significantly inhibit
protease protection of EGFR compared to cytosol isolated from parental strains
(lane 2 compared to 1). Reactions incubated with cytosol isolated from vps1Δ strains
or vps1Δ strains plus dynamin1 did not alter protease protection of EGFR compared
to cytosol isolated from a parental strain (lane 2 and 3 compared to lane 1). c) HeLa
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cells express Rab11S25N. Data represents the mean +/- S.E (n=3) normalized to
the control. *denotes p < 0.05.
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6.2. EGFR buds outwardly from late endosomal compartments.
My previous experiments were performed using endosomes that contain a
mixture of early and late endosomal populations. While early endosomes are
thought to mature into late endosomes by acquiring and discarding peripheral
membrane proteins, it is not clear when endosomes are competent to sort
membrane proteins and invaginate their limiting membranes to produce MVBs. To
determine whether early and late endosomal populations can bud EGFR-containing
vesicles, I separated these populations for use in our cell-free reactions. Post
nuclear supernatant from lysed cells was separated using Optiprep gradients and
gradient fractions were examined for the presence of markers for endosomal
compartments (EEA1 for early endosomes, LAMP1/Rab7 for late endosomes,
RAB11 for recycling endosomes) as well as EGFR and TfR (Fig 6.4b).

Early

endosomal membranes (fractions 8 and 9) and late endosomal membranes
(fractions 3 and 4) were collected and incubated in separate reactions containing
ATP and yeast cytosol. I observed that inward and outward budding of EGFRimmunoreactivity occurred from both endosomal populations (Fig. 6.4c and Fig.
6.4d). Reactions containing cytosol isolated from the hse1Δ yeast strain produced
significantly increased EGFR immunoreactivity in supernatant from reactions
containing late endosomal membranes compared with cytosol isolated from the
parental yeast strain, suggesting that ESCRT-0 deletion increased outward budding
from late endosomes. In contrast, there was no increase in EGFR-immunoreactivity
in supernatant from reactions containing early endosomal reactions and incubated
with hse1Δ cytosol compared to the parental yeast strain, suggesting that outward
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budding from the early endosome is not altered by ESCRT-0 protein deletion (Fig.
6.4c, lane 2 compared to lane 1). The protease protection of the EGFR was
significantly decreased in reactions containing either early or late endosomal
membranes and incubated with hse1Δ cytosol (Fig. 6.4d, lane 2 compared to lane 1)
suggesting that both membrane populations I isolated can invaginate and protect
EGFR in an ESCRT-dependent manner. Reactions containing cytosol isolated from
the vps1Δ yeast strain produced significantly decreased EGFR immunoreactivity in
supernatant from reactions containing either early or late endosomal membranes,
suggesting that dynamin deletion decreases outward budding from both membrane
populations (Fig. 6.4c, lane 3 compared to lane 1). Vps1Δ cytosol had no significant
effect on protease protection of EGFR in either population (Fig. 6.4d, lane 3
compared to lane 1), suggesting it is not required for internal vesicle formation of
MVBs. In summary, our results suggest dynamin facilitates outward budding from
the late endosome/MVB.
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Figure 6.4. EGFR buds outwardly from late endosomal membranes in a
dynamin dependent manner. Post-nuclear supernatant was loaded onto a
continuous 10-20% Optiprep gradient. a) Fractions were collected and the refractive
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index was measured. b) Fractions were immunoblotted for endosomal markers
(EEA1 for early endosomes, LAMP1/Rab7 for late endosomes, RAB11 for recycling
endosomes, EGFR, and TfR). c) Early endosomes (fractions 8 and 9) incubated
with cytosol isolated from hse1Δ strains did not alter EGFR immunoreactivity on
vesicles isolated from reaction supernatant compared to cytosol isolated from a
parental strain (lane 2 compared to lane 1). Late endosomes (fractions 3 and 4)
incubated with cytosol isolated from hse1Δ strains significantly increase EGFR
immunoreactivity on vesicles isolated from reaction supernatant compared to cytosol
isolated from a parental strain (lane 2 compared to lane 1) (p=0.042). Vesicles
isolated from reaction supernatant obtained from either early or late endosomes and
incubated with cytosol isolated from vps1Δ strains significantly decrease EGFR
immunoreactivity compared to cytosol isolated from a parental strain (lane 3,
compared to lane 1). d) Early and late endosomes incubated with cytosol isolated
from hse1Δ strains significantly decreased protease protection of EGFR compared
to compared to cytosol isolated from a parental strain (lane 2 compared to 1). Early
and late endosomes incubated with cytosol isolated from vps1Δ strains did not alter
protease protection of EGFR compared to cytosol isolated from a parental strain
(lane 3 compared to lane 1). Data represents the mean +/- S.E (n=3) normalized to
the control. *denotes p < 0.05 (t-test).
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Chapter 7. EGFRVIII inward and outward budding from the
MVB
Rationale:
Altered intracellular trafficking of membrane proteins may alter their cell
surface expression, modulate their signaling, and can be a significant driver of
disease. For example, an EGFR mutant, EGFRvIII, is internalized from the plasma
membrane but is not efficiently degraded compared to the wild-type receptor. This
pathogenic EGFR mutant constitutively recycles resulting in increased surface
expression, signaling, and proliferation, and is expressed in 50% of glioblastoma
cases (Frederick et al., 2000; Furnari et al., 2007; Gan et al., 2009; Heimberger et
al., 2005; Sugawa et al., 1990) where its presence correlates with aggressive
disease (Shinojima et al., 2003). Thus, elucidating the mechanism by which the
endocytic itinerary of EGFRvIII differs from that of the wild-type EGFR may provide
an understanding of a trafficking pathway important for disease.
7.1. EGFRvIII is sorted into internal vesicles of MVBs.
Although EGFRvIII is internalized from the plasma membrane, inhibition of its
degradation rate may result from slowed movement through the endocytic pathway.
This inhibited trafficking of EGFRvIII may occur at multiple steps during its movement
to the lysosome (Fig. 1.5). EGFRvIII is found on endosomes (Grandal et al., 2007)
suggesting that it passes through those organelles en route to lysosomes and may
therefore take the canonical MVB pathway to the lysosome. Initially, I determined
that EGFRvIII is internalized into internal vesicles of MVBs (Fig. 7.1a) by examining
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protease protection of an intracellular epitope as I had done previously for the wildtype receptor. I determined that in the absence of EGF stimulation, EGFRVIII is
present on endosomes and a portion of the receptor is protected from digestion into
internal vesicles of MVBs under basal conditions, suggesting that a pool of the
EGFRvIII moves through the endocytic pathway (Fig. 7.1b, lanes 4-6) into internal
MVB vesicles. In contrast, WT EGFR was not detected on endosomes in the
absence of EGF stimulation (Fig. 7.1b, lanes 1-3). Upon EGF stimulation, the
intracellular epitope of WT EGFR was protected from protease cleavage suggesting
that the WT EGFR has entered endosomes (Fig. 7.1b, lanes 7-9). These data
suggest that a pool of EGFRVIII can be sorted into internal vesicles of MVBs in a
ligand-independent manner.

7.2. Isolation of mutant EGFR outwardly budding vesicles.
To determine whether EGFRvIII buds outwardly from endosomal membranes,
partially purified endosomal membranes isolated from U87 cells expressing either
WT-EGFR or EGFRvIII were incubated with ATP and Saccharomyces cerevisiae (70
µg) cytosol for 3 hours at 37°C. Following incubation, reactions were centrifuged to
obtain outwardly budded vesicles. Characterization of this vesicle population using
light scattering and Brownian motion analysis (NTA) revealed that vesicles
containing WT-EGFR were found in a major peak with a hydrodynamic diameter of
107.8 +/- 12.4 nm (Fig. 7.2a). Similarly, NTA analysis revealed that vesicles
recovered from EGFRvIII expressing cells were found in a major peak with a
hydrodynamic diameter of 124+/-11.1 nm (Fig. 7.2b) suggesting that EGFRvIII
vesicles can be isolated from cell-free reactions and that there is no significant
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difference between the diameter of WT-EGFR and EGFRvIII outwardly budded
vesicles.

7.3. MVB Budding of EGFR and EGFRvIII is dynamin-dependent.
My previous results suggest that dynamin is required for outward vesicle
budding of EGFR from late endosomes (Fig. 6.2 and Fig. 6.4). To determine whether
dynamin is required for endosomal budding of EGFRVIII, partially purified endosomal
membranes isolated from U87 cells expressing either WT-EGFR or EGFRvIII were
incubated with ATP and Saccharomyces cerevisiae (70 µg) cytosol for 3 hours at
37°C. Following incubation, reactions were centrifuged and supernatant was
collected for additional centrifugation to obtain outwardly budded vesicles. The
budding of WT-EGFR and EGFRvIII was inhibited in vesicles isolated from reaction
supernatant in reactions lacking dynamin (vps1Δ) compared to parental strains (Fig.
7.3 a and c, lane 2 compared to lane 1). Protease protection of WT-EGFR or
EGFRvIII, a measure of inward budding, was not affected by the lack of VPS1 (Fig.
7.3 b and d, lane 2 compared to lane 1). Thus, both WT-EGFR and EGFRvIII are
internalized into endosomes and can bud from endosomal membranes in a dynamin
dependent manner, suggesting that EGFRVII can follow a similar endocytic trafficking
pathway to the EGFR.
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Figure 7.1. EGFRvIII can bud inwardly into internal vesicles of the MVB. a) HeLa
cells were transfected with WT-EGFR or EGFRvIII constructs. b) Endosomal
membranes (5 µL, lanes 1, 4, and 7) and endosomal membranes (5 µL) digested
with trypsin to remove the C-terminal epitope of the receptor (lanes 2, 5, and 80 as
well as partially purified endosomal membranes (15 µL) incubated in reactions
containing ATP and mammalian cytosol (25 µg) (lanes 3, 6, and 9) were treated in
the absence of EGF stimulation (lanes 1-6) or presence of EGF stimulation (lanes 79). In absence of EGF stimulation, WT-EGFR is not present on endosomal
membranes and is not sorted into internal vesicles (lanes 1-3). In contrast, EGFRvIII
is sorted into internal vesicles in the absence of EGF stimulation (lanes 4-6). WTEGFR is sorted into internal vesicles when stimulated with EGF (lanes 7-9). n=2
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Figure 7.2. WT-EGFR and EGFRVIII outwardly budded vesicles are similar in
size. Partially purified endosomal membranes isolated from U87 cells were isolated
as described in Fig. 1.6. Following incubation, reactions were centrifuged and
supernatant was collected for additional centrifugation to obtain outwardly budded
vesicles. Nanosight tracking analysis was performed on isolated vesicles to measure
mean vesicle size. a) WT-EGFR isolated vesicles are 108+/-12.4% nm in size. b)
EGFRVIII isolated vesicles are 124+/-11.1 nm in size. There was no significant
difference in vesicles size and distribution between WT-EGFR and EGFRVIII. N=3
with representative analysis shown for both.
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Figure 7.3. EGFR and EGFRvIII bud outwardly in a dynamin-dependent manner.
Partially purified endosomal membranes isolated from U87 cells were isolated as
described in Fig. 1.6. Following incubation, reactions were centrifuged and
supernatant was collected for additional centrifugation to obtain outwardly budded
vesicles. a) Vesicles isolated from vps1Δ reaction supernatant of WT EGFR
endosomes, the amount of EGFR on outwardly budded vesicles was decreased
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compared to a parental strain (lane 2 compared to lane 1). b) WT EGFR reactions
incubated with cytosol isolated from vps1Δ strains did not alter the protease
protection of EGFR compared to a parental strain (lane 2 compared to lane 1). c)
Vesicles isolated from vps1Δ reaction supernatant of EGFRvIII endosomes, the
amount of EGFRVIII on outwardly budded vesicles was decreased compared to a
parental strain (lane 2 compared to lane 1). EGFRVIII reactions incubated with
cytosol isolated from vps1Δ strains did not alter the protease protection of EGFRVIII
compared to a parental strain (lane 2 compared to lane 1). Data represents the
mean (n=2) normalized to the control. These experiments were performed in part by
Natalie Sirisaengtaksin and used with permission.
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Chapter 8. Discussion and Future Directions
The number of signaling membrane proteins on the cell surface, and the time
they spend in an activated state, are critical determinants for cellular responses to
extracellular

cues

that

can

regulate

homeostasis,

plasticity,

growth,

and

differentiation (Maxfield and McGraw, 2004; Gruenberg and Stenmark, 2004;
Katzmann, 2002; Tanowitz and von Zastrow, 2003; Donaldson and Dutta, 2016;
Grant and Donaldson, 2009). Internalization and movement through the endocytic
pathway is required to tune the signaling responses of various membrane proteins.
After movement through multiple, morphologically defined, compartments of the
endocytic pathway, membrane protein signaling is attenuated upon their lysosomal
degradation (Gruenberg, 2001; Sorkin and von Zastrow, 2009; Sun et al., 2010;
Yang et al., 2005).
A membrane protein that transits the endocytic pathway and arrives at the
limiting membrane of the MVB either buds inwardly into the internal vesicles for
eventual degradation in the lysosome, remains on the limiting membrane for
incorporation into lysosomal membranes upon MVB-lysosome fusion, or is
transported into vesicles that bud outwardly from the MVB for movement to various
cellular compartments (Grant and Donaldson, 2009; Gruenberg, 2001; Maxfield and
McGraw, 2004; Tanowitz and von Zastrow; Thompson et al., 2007; Weigert et al.,
2004). While outward budding from the late endosome has been suggested (Felder
et al., 1990), my data provides the first reported isolation of vesicles that bud
outwardly from MVBs. These outwardly budding vesicles could provide a
mechanism by which membrane proteins are transported out of the late endocytic
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pathway to other cellular compartments (Felder et al., 1990). The ability to isolate
outwardly budding vesicles allowed an examination of the molecular machinery
regulating the budding event and to characterize these vesicles. These studies also
allowed comparison of the mechanisms underlying inward and outward budding
from the same endosomal membrane and resulted in an appreciation of the
differences in molecular machinery required for these unique budding events.
Interestingly, while differences in the mechanisms of the budding events were
evident, I also observed that the budding processes are linked such that inhibition of
inward budding enhances outward budding.
8.1. Mechanisms of inward budding at the MVB
Since both budding events I measured are dependent on cytosolic
components, and cytosol isolated from yeast and fly are able to support these
budding events, I used genetic approaches to interrogate the cytosol for molecules
involved in the regulation of MVB budding. I found that ESCRT complex components
are required for the protease protection of a cargo protein (EGFR), confirming that
these molecules are involved in inward MVB budding in our reconstituted system. In
this regard, cytosol isolated from yeast strains deleted of either of the ESCRT-0
proteins impaired membrane protein budding into internal vesicles, an effect that
was rescued by the addition of the soluble mammalian orthologous ESCRT proteins.
While EGFR was used as a proxy for membrane protein cargo, I found that multiple
types of membrane proteins follow the same internal budding pathway [e.g. tyrosine
kinase receptors (Fig. 4.1), GPCRs (Fig. 4.2), ion channels (Fig. 4.3) in an ESCRT0-dependent manner. Thus, reconstitution of this budding event allows examination
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of a variety of cargo proteins and the underlying mechanisms by which this budding
event occurs.
Similar to ESCRT-0 components, deletion of ESCRT-I impaired EGFR
budding into internal MVB vesicles. These data are consistent with previous studies
reporting that ESCRT-I is required for membrane protein movement into internal
vesicles (Bache et al., 2004; Doyotte et al., 2005). However, the role of ESCRT-II in
membrane protein movement into internal vesicles is controversial. Previous studies
suggest that ESCRT-II is dispensable for inward budding of cargo including the
EGFR and major histocompatibility complex class I (MHC-I) (Bowers et al., 2006;
Malerod et al., 2007). However, others have found that ESCRT-II is required for
EGFR and ferroportin degradation, and not required for MHC-I degradation
(Langelier et al., 2006; Williams and Urbe, 2007). To address the controversy, I
measured inward budding of the EGFR and used cytosol lacking ESCRT-II proteins,
allowing a direct and unambiguous examination of the role of these molecules. Our
results suggest that all components of that ESCRT-I and ESCRT-II are required for
inward budding of the EGFR into internal MVB vesicles.
Interestingly, deletion of only two of the four ESCRT-III genes, SNF7 and
VPS24 inhibit the movement of EGFR from the endosomal membrane into internal
vesicles. These data are consistent with previous studies reporting that deletion of
SNF7 or VPS24 inhibit degradation of EGFR (Bache et al., 2006; Shim et al., 2006).
Somewhat surprisingly, deletion of the ESCRT-III genes VPS20 and DID4 failed to
inhibit protease protection of the EGFR. To determine whether components of the
two major ESCRT-III complexes (Vps20/Snf7 and Vps24/Did4) may have redundant
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or overlapping roles (Babst et al., 2002a) I examined EGFR protease protection in
reactions using cytosol from yeast strains in which double deletions were made in
ECSRT III genes. Double deletions (Vps20/Snf7 or Did4/Vps24) did not inhibit the
protease protection of EGFR significantly more than cytosol from single deletion
(snf7Δ or vps24Δ) strains, suggesting that the ESCRT-III components Vps20 and
Did4 are not required for the inward budding of EGFR-containing vesicles. The
ESCRT-III complex has been suggested to drive membrane fission events that allow
internal vesicle formation within MVBs, as well as viral budding events, and
cytokinesis (Adell and Teis, 2011; Hurley and Hanson, 2010; McDonald and MartinSerrano, 2009).

It has been hypothesized that Vps20 binds to ESCRT-II and

recruits Snf7, which in turn recruits the remaining ESCRT-III components for MVB
budding (Adell and Teis, 2011; Hurley and Hanson, 2010). In cytokinesis and viral
budding events Vps20 is dispensable and Snf7 binds to an ESCRT-associated
protein, Bro1, which directly activates Snf7 and the remaining ESCRT-III
components (Carlton and Martin-Serrano, 2007; Martin-Serrano et al., 2003;
Wemmer et al., 2011). In a manner similar to cytokinesis and viral budding, my
results show that Vps20 is not required for membrane protein budding into internal
vesicles of MVBs, suggesting that Snf7 may be directly activated through binding of
other proteins (e.g. Bro1). After formation of the Vps20/Snf7 complex, the
Vps24/Did4 complex is thought to act as a cap for Snf7 (Adell and Teis, 2011;
Hurley and Hanson, 2010). Previous studies suggested that Did4 is not required for
membrane scission, but instead is required for disassembly of ESCRT complexes,
by initiating the recruitment of Vps4 (Williams and Urbe, 2007; Wollert et al., 2009).
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My results are consistent with the hypothesis that Did4 is not required for membrane
protein sorting at the MVB.
The ESCRT machinery plays a role in cargo sorting and MVB vesicle
formation however increasing evidence suggests that lipids may play a key role in
regulating internal vesicle formation (Babst et al, 2010). ESCRT-0 localizes to lipid
rafts through binding of Hrs to phosphatidylinositol 3-phosphate (PI3P) (Gaullier et
al., 1998; Petiot et al., 2003; Schmidt and Teis, 2012; Stenmark et al., 2002) and
may therefore help to sort cargo into these lipid domains. Interestingly, ESCRT
deletion inhibits cargo sorting but not internal vesicle formation (Babst; Sun et al.,
2010), suggesting that ESCRTs regulate cargo formation but lipids may play a larger
role in regulating internal vesicle formation. Lipid clustering causes formation of lipid
rafts that may help membrane deformation, ultimately leading to vesicle formation
(Babst, 2011; Bissig and Gruenberg, 2013). Cholesterol is enriched in lipid rafts and
is concentrated on internal MVB vesicles (Mobius et al., 2003), suggesting that
cholesterol may be required for internal vesicle formation. We observed that
cholesterol depletion inhibits protease protection of the EGFR implying that
cholesterol is required for inward vesicle budding. Cholesterol is required for
formation of highly curved structures such as synaptic vesicles (Mobius et al., 2003;
Wang et al., 2007), suggesting that a similar cholesterol-dependent mechanism
might underlie inward budding of similar sized endosomal vesicles.
8.2. Characterization of outwardly budded vesicles from MVBs
Transport from MVBs to other cellular compartments, including the Golgi and
plasma membrane, likely require an outward vesicle budding event to cluster cargo
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and allow for targeted movement (Felder et al, 1990; Nicoziani and van Deurs,
2000). I have isolated and characterized vesicles that bud outwardly from MVBs
during our cell-free reactions. The vesicles are approximately 100nm in size and
contain EGFR. To isolate these outwardly budding vesicles I used yeast cytosol (that
does not contain detectable EGFR) in place of mammalian cytosol, to enable
definitive measurement of the amount of EGFR that is transported from the
endosome. Analysis of these vesicles by mass spectrometry identified many
proteins known to be involved in protein trafficking steps (Table 2). Clarifying the role
these proteins play in the outward budding step from MVBs may provide insight into
the trafficking of these vesicles. For example, the SNARE proteins mediate vesicle
fusion events (Sudhof and Rothman, 2009), and identification of 4 SNARE proteins
(e.g. Vamp2, Vamp3, Sec22B, SNAP91) in our analysis provides clues to potential
fusion mechanisms and destinations for these vesicles. Vamp2 regulates the fusion
of intracellular vesicles with the plasma membrane through binding to the plasma
membrane protein syntaxin1 (Salaun et al., 2004). Vamp3 mediates fusion of the
Rab11 recycling compartment with the plasma membrane by binding to Syntaxin4
and SNAP23 (Veale et al., 2010). SEC22B binds to syntaxin18, a resident SNARE
on the Endoplasmic Reticulum (ER) (Hatsuzawa et al., 2009) and is required for
Golgi-ER and ER-Golgi Transport (Chatre et al., 2005). SNAP91 binds to the clathrin
coat protein and regulates clathrin-mediated endocytosis (McMahon and Boucrot,
2011). Therefore, vesicles may be transported to the plasma membrane, ER or the
Golgi. Similarly, the mass spectrometry results identified three retromer protein
components (e.g. SNX2, Vps29, Vps35). The retromer complex regulates recycling
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of receptors to the trans-Golgi and the plasma membrane (Arighi et al., 2004;
Seaman, 2004; Steinberg et al., 2013) and consists of 5 components (e.g. VPS35,
VPS29, VPS26, SNX1, and SNX2) (Carlton et al., 2004; Haft et al., 2000; Steinberg
et al., 2013). Identification of retromer proteins suggests that a subset of vesicles
may be transported to the plasma membrane or Golgi in a retromer-dependent
manner. Additional proteins identified in our analysis include coat proteins (e.g.
Clathrin, COPs), adaptor proteins (e.g. AP1, AP2) and Dynamin2. Thus, the vesicle
components identified by Mass spectrometry provide guidance for understanding the
mechanisms and destination of the outwardly budded vesicles.
My studies isolated and identified the cargo constituents of outward budding
vesicles, however the destination of these vesicles was still unclear. Therefore, I
took advantage of the known itinerary of an EGFR mutant lacking kinase activity,
EGFRK721A, that traffics to the limiting membranes of MVBs prior to budding onto
vesicles that ultimately fuse with the plasma membrane (Felder et al., 1990). I found
EGFRK721A on the outwardly budding vesicles, suggesting that these vesicles were
budding from the MVB and therefore, that at least some proportion of the outwardly
budding vesicles I isolate are targeted to the plasma membrane. Interestingly, Felder
et al, 1990 found 25% of the EGFRK721A on internal endosomal vesicles, 42% on
recycling vesicles, and 33% on the limiting endosomal membrane (Felder et al.,
1990).

By comparison, I found a similar percentage of EGFRK721A present on

internal vesicles, however I observed a lower percentage of EGFRK721A on outwardly
budded vesicles perhaps due in part to a low recovery of outwardly budded vesicles
in our biochemical assay.
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8.3. Endosomal trafficking of EGFR in response to varying ligand concentration
Challenging tumor cells with high concentrations of EGF results in
internalization of the ligand-receptor complex by both clathrin-mediated endocytosis
and clathrin-independent pathways (Sigismund et al., 2008). In contrast, stimulation
of the same cells with low EGF concentrations results in internalization only via
clathrin-mediated endocytosis (Sigismund et al., 2008). Thus, engagement of
different internalization pathways has been hypothesized to be necessary to tune
cellular responses of enhanced levels of extracellular EGFR (Chandra et al., 2013;
Sigismund et al., 2008). High extracellular EGFR concentrations increase cellular
proliferation and signaling (Chandra et al., 2013; Sorkin, 2001) I observed that
stimulation of tumor cells with either low or high EGF concentrations results in both
inward and outward endosomal vesicle budding. However, the ratio of inward to
outward budding from the MVB membrane did not differ based on ligand
concentration used for EGFR stimulation. My results are in agreement with a report
suggesting that 25-30% of EGFR recycles and 40-50% of EGFR degrades when
cells are treated with a range of EGF (5-200ng) (Sorkin et al., 1991) suggesting that
any differences in internalization of EGFR may play a role in EGFR trafficking during
early parts of the endocytic pathway (Fig. 1.1 and Fig. 1.4) but do not result in
differences at the MVB membrane.
8.4. Mechanisms of outward budding from MVBs
By reconstituting both inward and outward budding from the same endosomal
membranes I was able to compare these budding events. As I observed for inward
budding, I found that outward vesicle budding from MVBs was also dependent on
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cytosolic components. To identify the specific cytosolic components that are required
for the outward budding event I have taken multiple approaches. Initially, I took a
candidate approach and chose to examine selected GTPases as it has been
appreciated for many years that these molecules are required for various vesicle
budding steps (Baker et al., 1990; Beckers and Balch, 1989; Melancon et al., 1987;
Ruohola et al., 1988; Tooze et al., 1990). In this regard, outward budding from early
endosomes is dependent on the GTPases Rab4, Rab5, and Rab11 (Kobayashi and
Fukuda, 2013; van Dam and Stoorvogel, 2002). Rab11 regulates the slow recycling
pathway (Grant and Donaldson, 2009; Ren et al., 1998; Ullrich et al., 1996), and
thus is more indicative of a mechanism that may regulate late endosomal outward
budding. However, my results suggest that outward budding from the MVB is Rab11
independent. This suggests a different molecular mechanism regulates MVB
budding. I examined whether the ESCRTs were involved in outward budding in
addition to an unbiased approach to examine proteins that may regulate outward
budding from the MVB.
A relationship between inward MVB budding and recycling was suggested by
Babst et al, (Babst et al., 2000) who found that deletion of ESCRT proteins resulted
in an increase in EGFR recycling. In these experiments, EGFR was measured at the
plasma membrane although the compartment from which it was recycled (e.g. early
or late endosomes) was unresolved (Babst et al., 2000). In the reconstituted system,
I found that deletion of an ESCRT-0 component increased outward vesicle budding
from the limiting membrane of the MVB, but not from early endosomes. My result is
consistent with Babst et al (Babst et al., 2000) but identifies the MVB as an
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endosomal compartment from which EGFR may originate for plasma membrane
recycling.
The increased outward vesicle budding that occurs when inward budding is
inhibited provides insight into the role cargo proteins may play in vesicle formation
and the linkage between cargo proteins and the ESCRT machinery. One hypothesis
(elevator hypothesis) (Robinson, 2004; Santini and Keen, 1996; White et al., 2006)
suggests that vesicle formation/budding is dependent on the presence of membrane
protein cargo, while another hypothesis (escalator hypothesis) (Santini and Keen,
1996) posits that vesicles form/bud regardless of whether cargo is present
(Robinson, 2004; Santini and Keen, 1996). Our data suggest that cargo plays a role
in vesicle formation, because inhibition of inward budding enhances outward
budding. If vesicle budding/formation occurs constitutively, one might expect that
outward budding would not be affected by inhibition of inward budding events.
Lastly, I took an unbiased approach to screen for genes that are required for
outward budding. I observed that cytosol isolated from a dynamin-deficient yeast
strain (vps1Δ) inhibited outward budding in our cell-free assay, an effect that could
be partially rescued by mammalian dynamin 1. The partial rescue may be a result of
using the mammalian protein to rescue the yeast deletion or that other dynamin
isoforms are required to fully rescue the inhibition of outward budding. In this regard,
dynamin 1 and 2 have been speculated to have overlapping functions in endocytosis
(Ferguson et al., 2009; Liu et al., 2008) and we identified dynamin 2 as a constituent
of outwardly budded vesicles (Table 2). Dynamin has been localized on late
endosomal membranes and regulates the late endosome-Golgi recycling of the
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mannose-6-phosphate receptor (Nicoziani et al., 2000). Therefore, a subset of our
isolated vesicles may be transported to the trans-Golgi network or dynamin may
regulate outward vesicle budding from late endosomes to the plasma membrane.
8.5. ESCRT assembly and cargo sorting may provide a clue to the link between
inward and outward budding from MVBs
My data also makes a contribution to understanding how ESCRT complexes
enable cargo sorting at the endosomal membrane. The conveyor belt model (Hurley
and Emr, 2006) suggests that cargo molecules are handed off sequentially from one
ESCRT complex to the next in a linear fashion. The concentric ring model
(Nickerson et al., 2007) suggests that multiple cargoes are clustered beneath an
ESCRT supercomplex. Our data are in favor of the concentric ring model.

If

membrane cargo is clustered as suggested by the concentric ring model and inward
budding is inhibited, the cargo clusters would begin to accumulate on MVB
membranes, leading to an increase in endosome size. Therefore, to limit cargo
accumulation on the MVB limiting membrane and ensure consistent MVB size, cargo
clusters are transported to other cellular compartments, leading to an increase in
outward budding from MVBs, consistent with what I have observed. The linkage
between inward and outward budding may be due in part, to the localization of cargo
clusters and the machinery regulating inward and outward budding on the MVB
membrane. The ESCRT-0 component, Hrs, is found clustered in areas that
contained EGFR (Sachse et al., 2002; Tsujimoto et al.). Interestingly, coat proteins
are known to regulate budding events, and one such coat protein, clathrin, is found
in clusters adjacent to the Hrs clusters (Sachse et al., 2002), suggesting that ESCRT
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and Clathrin clusters are adjacent but not overlapping on the endosomal membrane
in membrane domains that may correspond those undergoing inward and outward
budding. It is therefore possible that under conditions that inhibit inward budding,
cargo is budded outwardly due to the close spatial arrangement of the machinery
that regulates these distinct budding events.
8.6. EGFRvIII can be internalized into internal vesicles of the MVB
Mutations in membrane proteins can result in aberrant trafficking that results
in disease. For example, EGFRvIII is a pathogenic variant of EGFR found in a high
percentage of glioblastoma tumors (Padfield et al., 2015), and results in aggressive
disease.

Interestingly, increased EGFRvIII recycling that results in increased

downstream signaling is thought to underlie glioblastoma tumorigenesis (Grandal et
al., 2007). My results suggest that at least a portion of EGFRvIII can bud inwardly into
internal vesicles of MVBs, suggesting that at least a pool of this mutant receptor can
be degraded in the lysosome. However, I observed that EGFRvIII is also found on
outwardly budding endosomal vesicles and that dynamin is required for the outward
budding of EGFRVIII. Thus, EGFRvIII buds inwardly and outwardly from endosomal
membranes suggesting that a therapeutic strategy might involve shifting the balance
of degraded/recycled EGFRvIII. One caveat to this interpretation is that internalization
of EGFRvIII into internal vesicles of the MVB does not always imply that the receptor
will be degraded in the lysosome. MVBs can also fuse with the plasma membrane
and release the internal vesicles into the extracellular space as “exosomes”
(Corrado et al., 2013; Hurley and Odorizzi, 2012; Kowal et al., 2014).

In

glioblastoma patients, EGFRvIII has been found on exosomes (Skog et al., 2008).
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These results suggest that MVBs containing EGFRvIII may fuse with the plasma
membrane instead of the lysosome.
8.7. Future Directions
1. To further characterize vesicles that bud outwardly from isolated late
endosomal membranes.
Analysis of the outwardly budding vesicles by Mass Spectrometry revealed
the identity of proteins known to be involved in protein trafficking steps. Future
experiments will take advantage of this proteomic information to try to understand
whether there are multiple populations of budding vesicles that may carry distinct
cargo or may be targeted to different compartments. For example, the SNARE
proteins identified by Mass Spectrometry (e.g. Vamp2, Vamp3, Sec22B, SNAP91)
could be used to define potential target membranes and future experiments could try
to understand whether outwardly budded MVB vesicles with different SNAREs target
different compartments.

Moreover, the cargo carried by different populations of

vesicles could be identified. The role of vesicle SNAREs in the fusion of recycling
vesicles with plasma membrane and/or other cellular compartments could also be
addressed.
2. To identify cytosolic components that regulate MVB budding.
My studies took advantage of a yeast deletion library in a limited screen for
genes that are required for outward budding. Future experiments could include a
large-scale screen using yeast cytosol that could identify proteins that regulate
inward and outward budding events.
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3. To determine the mechanistic link between inward and outward budding
from MVBs.
Inhibition of inward budding resulting from deletion of the ESCRT machinery
increases outward vesicle budding from MVBs, suggesting that the two mechanisms
of budding may be linked. It is possible that outward budding is a bulk-flow process
that is enhanced when inward budding is inhibited. Ubiquitination may trigger cargo
clustering and assembly of ESCRT complexes, as suggested in the concentric ring
model. In the absence of ESCRT recruitment, cargo that is ubiquitinated may
become deubiquitinated, not able to enter inwardly budding vesicles, and be
transported to other cellular compartments. This hypothesis could be examined by
determining whether inhibition of inward budding by blocking ubiquitination (or
enhancing deubiquitination) results in increased outward budding.
4. To determine the trafficking pathway of EGFRVIII.
Our results suggest that a percentage of EGFRVIII can bud inwardly into
internal vesicles of MVBs. MVBs can fuse with the lysosome to degrade the contents
of the internal vesicles, or they can fuse with the plasma membrane and release the
internal vesicles as exosomes. The destination of EGFRvIII containing MVBs is
unknown but the lack of considerable EGFRvIII degradation suggests that these
MVBs may fuse with the plasma membrane. Comparing the cargo constituents of
MVBs containing EGFRvIII with MVBs containing wild-type EGFR may allow
understanding of differences in cargo and fusion machinery required for MVBlysosome versus MVB-plasma membrane fusion.
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